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Abstract.
Slalp is a protein required for cortical actin patch structure and organisation in budding 
yeast. An association with the endocytic machinery has also been shown by 
immunoprécipitation of Slalp with EH domain containing proteins, Bnd3p and Panlp.
Here we use immunofluorescence to demonstrate that localisation of Slalp to the cell 
cortex requires its C-terminal repeat region and also End3p. We show that cells either 
lacking SLAl or expressing the slalACt mutant display defects in both fluid phase and 
receptor mediated endocytosis, suggesting that Slalp may be part of the endocytic 
machinery.
This study also demonstrates modification of Slalp by the Actin Regulating Kinases, 
Arklp/Prklp and the yeast protein phosphatase-1 Glc7p. Immunofluorescence microscopy 
revealed that the association of Slalp with cortical actin patches is regulated by the 
interactions of the Arklp/Prklp kinases. We also provide evidence for the existence of 
multiple isoforms of Slalp in vivo.
Finally, using the yeast 2-hybrid system, we identified Ycl034wp and Ynr065cp as 
interacting partners of the central region of Slalp. Sequence analysis of Ycl034wp 
predicted this protein contained a VHS and a GAT domain. These domains have been 
identified in a number of proteins involved in vesicle trafficking. The mammalian 
homologues of Ynr065cp (Sortilin and Sorl-1) have also been implicated in vesicle 
trafficking. This indicates that the central region of Slalp interacts with proteins involved 
in the transport of vesicles.
Taken together, the data presented here allows us to predict a dynamic model where Slalp 
is able to interact with proteins involved in actin dynamics, the endocytic machinery and
ii
also proteins involved in vesicle trafficking. Association of these different sets of 
machinery may be regulated by cycles of phosphorylation and dephosphorylation. This 
allows Slalp to function as an adaptor protein, bringing proteins involved in different 
stages of the endocytic pathway into close proximity and allowing efficient endocytosis.
in
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Chapter 1. 
Introduction.
1.1 Actin.
Actin is ubiquitously expressed in eukaryotic cells and is required for a wide range of 
cellular processes including endocytosis, exocytosis, cell motility, cell polarity and 
cytokinesis. Its importance to the functions of cells is reflected in the very high level of 
sequence conservation throughout eukaryotes. For example, there are no amino acid 
substitutions between chicken skeletal muscle actin and human skeletal muscle actin 
(Sheterline et al, 1995) and yeast actin shares 88 % amino acid identity with human skeletal 
muscle actin. The high degree of sequence conservation suggests that actin is a protein 
which has essential cellular functions in all eukaryotes.
Two pools of actin exist in cells, monomeric G-actin and filamentous F-actin. The pool of 
F-actin is the 'functional form’ of actin, as most of the known biological functions of actin 
require it to be in the filamentous form. The pool of G-actin may act as a store of actin to 
allow rapid polymerisation of F-actin structures when required. Unlike mammalian cells, 
yeast do not contain a large pool of G-actin and most of the actin is present in the 
filamentous form in these cells. G-actin has been measured at about 0.015 ng//xg of total 
cell protein and the total actin measured at 1.5 ng/jUg of total cell protein. This means that 
G-actin represents only about 1 % of the total yeast actin (Karpova et al, 1995; Karpova et 
al, 1998). The reason for yeast cells lacking a large pool of G-actin is most probably 
because these cells are non-motile, so require less actin in the monomeric actin to allow 
rapid assembly of new actin structures.
Many proteins control actin polymerisation and depolymerisation within cells. These 
include proteins that sever or cap actin filaments, nucleate polymerisation, cross-link and 
stabilise actin filaments (for review see Ayscough, 1998). Others bind to G-actin, 
maintaining up to 50% of cytoplasmic actin as monomers (Korn, 1982) and are able to 
respond to signals by releasing G-actin and allowing its polymerisation (Lassing and 
Lindberg, 1985). Filamentous actin is found in a variety of supramolecular assemblies such 
as networks, foci and bundles. The two pools of actin are highly dynamic and change size 
and distribution throughout development and differentiation.
The atomic structure of monomeric actin complexed with DNAse I (Kabsch et al, 1990), 
gelsolin segment-1 (McLaughlin et al, 1993) and profilin (Schutt et al, 1993) have been 
determined. The 375-residue polypeptide is arranged into two domains, each of which are 
comprised of two subdomains (Figure 1.1). The large domains are organised to form a 
hinged molecule containing a deep cleft into which the actin essential cofactors, ATP/ADP 
and divalent cations bind (Kabsch et al, 1990). Although a number of high resolution 
crystal structures have been reported for complexes of G-actin with actin binding proteins, 
currently there are only models for the actin filament structural. F-actin can be induced to 
form orientated arrays that can be used to generate low-resolution structural information by 
fibre diffraction. These models predict that actin filaments are dimers of two 
protofilaments that form a helical structure and contain uniformly orientated actin 
molecules (Holmes et al, 1993). They are polar structures with two structurally and 
biochemically different ends, a slow growing pointed end and a faster growing barbed end.
1.2 Polymerisation of actin.
Polymerisation of actin in vitro requires ATP as well as monovalent (K"'") and divalent (Ca^  ^
or Mg^ "^ ) cations. Initally there is a lag phase, as new filaments are nucleated, and then
Siilxlonuiiii 4.- % ' S i i I h U ' i i k i i i i  2.
d  ' 4^ ^
\ .y SiilHlom;iin I.
SiilxU'DKiin 4.  ^ T
i J  ~M
Figure 1.1. The atomic structure of G-actin complexed with DNAse I. ATP and the 
calcium ion are located in the cleft between the two large domains. Adapted from 
SwissProt NCBI (http://www.ebi.ac.uk/swissprot/).

a rapid polymerisation phase, as short filaments elongate. Actin filaments form by the non- 
covalent association of actin monomers that contain ATP in their nucleotide-binding cleft. 
After incorporation of an actin monomer into the filament, ATP is hydrolysed to ADP and 
this hydrolysis is accompanied by a conformational change (Lorenz et al, 1993; Tirion et 
al, 1995).
The critical property of actin is that the filaments are polarised and dynamic. The nature of 
the filament is such that ATP-actin molecules are added continually to the barbed end 
whereas ADP-actin is lost continually from the pointed end of a filament. This process 
requires an energy input via ATP hydrolysis and is thought to contribute to the rapid 
exchange of subunits of the actin filaments observed in cells.
1,3 Using yeast to test predictions from structural information.
Information generated from atomic structure of actin has allowed prediction of the roles of 
various actin domains. Residues that surround the cleft region are likely to be involved in 
binding or hydrolysis of the nucleotide. Other regions of actin are potentially involved in 
making essential contacts for filament formation or for interactions with actin binding 
proteins. Due to the high degree of sequence and structural similarities between budding 
yeast actin and actin from higher eukaryotes, yeast have proven to be a powerful tool 
allowing the predictions from these studies to be tested.
A systematic mutational scan of ACTl, in which charged residues were replaced by alanine 
(Wertman et al, 1992) has been particularly valuable. Characterisation of the alleles 
generated has provided insights into functions and interactions of actin and has been used to 
map the binding sites for actin binding proteins (Honts et al, 1994; Belmont et al, 1998; 
1999) and actin associating drugs. For example, residues important for binding of the
adenine nucleotide were proposed, based on the atomic structure (Kabsch et al, 1990). A 
point mutation in one of these residues (Q137A) has been shown to disrupt the hydrogen 
bonding to the ATP molecule. This mutant displayed a variety of phenotypes including 
slow actin filament turnover, slow fluid phase endocytosis and defects in their actin 
organisation (Belmont et al, 1998; 1999).
A study carried out by Honts and others mapped the Sac6p (fimbrin) interacting site on the 
actin molecule. They identified eight actl alleles that showed suppression with sac6 
mutant alleles. Sequence analysis revealed all mutations altered residues that cluster to a 
small domain of the actin crystal structure. Biochemical analysis demonstrated defects in 
the ability of several mutant actins to bind Sac6p and a reduction in the Sacôp-induced 
cross-linking of mutant actin filaments (Honts et al, 1994).
More recently the Latrunculin-A (LAT-A) binding site has been mapped on the actin 
molecule. LAT-A can disrupt the actin cytoskeleton in yeast cells (Ayscough et al, 1997). 
This has enabled the identification of point mutations in the actin gene that cause cells to 
become resistant to the effects of the drug. Sequence analysis of the mutations revealed 
that they were all clustered close to the nucleotide-binding site of the actin crystal structure 
(Ayscough et al, 1997). The crystal structure of actin bound to LAT-A has been resolved 
and indicates that LAT-A may act by interfering with conformational changes that are 
necessary for polymeriastion (Morton et al, 2000). When the LAT-A binding site is 
occupied, ATP is clamped within the actin filament and the filament is stablised (Morton et 
al, 2000).
1.4 The actin cytoskeleton of budding yeast.
In yeast filamentous actin primarily exists in cortical patches and cytoplasmic cables. The 
cortical patches are discrete F-actin rich structures and the cables are comprised of long 
bundles of F-actin. Both forms of F-actin become polarised in a cell-cycle dependent 
manner (Figure 1.2) (for review see Pruyne and Bretscher, 2000).
At some point during the cell cycle a predetermined bud site is selected. Cortical actin 
patches concentrate at this site and form a ring structure while cables run parallel along the 
mother-bud axis. As the bud emerges, cortical actin patches are located in the bud and 
cables remain parallel to the mother-bud axis, extending from the mother cell to the newly 
forming bud. Patches and cables redistribute randomly between the mother and bud while 
an F-actin cytokinetic ring assembles at the bud neck, contracts and finally disassembles. 
After cytokinesis both cortical patches and cytoplasmic cables re-polarise to the former bud 
neck to allow synthesis of cell wall between the two cells.
1.5 Actin binding proteins in yeast.
The organisation of the budding yeast actin cytoskeleton changes through the cell cycle and 
also in response to external signals, such as yeast pheromones (for review see Pruyne and 
Bretsher, 2000). This demonstrates the requirement for cells to remodel the actin 
cytoskeleton in response to both intracellular and extracellular signals. Actin binding 
proteins allow cells to regulate actin dynamics and control the assembly/disassembly of 
actin monomers into higher order structures (figure 1.3). Much of our understanding about 
the functions of actin binding proteins has come about from biochemical studies that have 
described how these proteins modify the state of actin filaments in vitro. It is also 
important to determine the functions of actin binding proteins in vivo. Due to the 
similarities that exist between the actin cytoskeleton in budding yeast and higher
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eukaryotes, yeast have proved to be a useful tool in studying the functions of these proteins 
in vivo (for review see Ayscough, 1998). A wide variety of actin binding proteins have 
been identified that allow cells to regulate the organisation of the actin cytoskeleton and 
some of these will be discussed in the following section.
1.5.1 Profilin.
Profilin is a small actin binding protein that has been identified in a wide variety of 
organisms (yeast, Drosophila and mammalian cells) (Christensen et al, 1996; Rothkegel et 
al, 1996). Although profilins from different organisms show moderate sequence 
conservation, 22% between plant and mammalian profilins, they have been demonstrated to 
complement each other. For example, plant profilin microinjected into mammalian cells 
was able to functionally substitute for endogenous mammalian profilin (Rothkegel et al, 
1996). Originally profilin was thought to sequester actin monomers (Carlsson et al, 1977), 
however the principle role of profilin is now thought to be in regulating actin dynamics.
The current idea is that profilin binds to a ADP-actin monomer to form a profilactin 
complex. Profilin then promotes exchange of ATP for ADP on actin (Mockrin and Korn, 
1980; Goldschmidt-Clermont et al, 1991), allowing rapid assembly at the barbed ends of 
actin filaments (Pantaloni and Carlier, 1993; Kang et al, 1999). Biochemical studies using 
yeast profilin revealed that profilin inhibits hydrolysis of ATP by monomeric actin (Haarer 
et al, 1990). Yeast cells lacking profilin grow extremely slowly, become large and round, 
lack dectable actin cables and no longer polarise their cortical actin patches (Haarer et al, 
1990). All of the evidence suggests that profilin serves to promote polymerisation of F- 
actin structures.
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1.5.2 The Cofilin/ADF family members.
The cofilin/ADF family members have been shown to bind both actin monomers and actin 
filaments in vitro and stimulate actin filament disassembly (Carlier et al, 1997). The 
association between cofilin and actin is inhibited by either phosphoinositides (Yonezawa et 
al, 1989, 1991) or phosphorylation (Morgon et al, 1993). The actin depolymerisation 
activity of cofilin is regulated in a pH dependent manner, being favoured in an alkaline 
environment (Yonezawa et al, 1985). Yeast cofilin is essential for the viability of yeast 
cells (lida et al, 1993; Moon et al, 1993), demonstrating the importance of disassembly of 
the actin filament network. Studies using partial loss of function alleles in the yeast cofilin 
gene (COFl) demonstrated that rapid cycles of actin filament assembly and disassembly 
depends on cofilin and that the F-actin binding and depolymerisation activity are the 
essential cofilin functions (Moon et al, 1993; Lappalainen et al, 1997).
1.5.3 Tropomyosins.
Tropomyosins are elongated shaped proteins that bind along the length of actin filaments, 
spanning several actin monomers (Ayscough et al, 1998). Tropomyosins share a moderate 
sequence homology, for example yeast Tpmlp shares a 20% amino acid identity with 
human TpmB. Deletion of the two tropomyosin encoding genes (TPMl and TPM2) from 
budding yeast is lethal (Drees et al, 1995). However, cells containing the temperature 
sensitive tropomyosin double mutant (tpml-2 tpm2A) contain no detectable cytoplasmic 
cables and have an aberrant cell morphology at the non-permissive temperature, suggesting 
that tropomyosin serves to stabilise actin filaments (Karpova et al, 1998). Subsitution of 
residues proposed to be involved in actin’s interaction with tropomyosin for alanine was 
lethal when expressed as the sole source of actin in cells (Lorenz et al, 1995). These data 
support the hypothesis that tropomyosins stabilise actin filaments by interacting with 
several actin subunits along the length of an actin filament.
10
1.5.4 Capping Proteins.
Capping proteins are ubiquitously expressed heterodimeric actin-binding proteins that 
contain a moderate to a high degree of sequence homology. For example yeast Cap Ip 
shares a 27% amino acid identity with human CAPZA whereas yeast Cap2p shares a 46% 
amino acid identity with human CAPZB. Capping proteins have been shown to nucleate 
actin polymerisation and to control filament length in vitro (for review see Schafer and 
Cooper, 1995). The budding yeast Cap Ip and Cap2p have been demonstrated to bind the 
barbed end of actin filaments preventing the addition or removal of actin monomers 
(Amatruda et al, 1992). Deletion of the genes encoding yeast capping proteins results in 
cells containing lower amounts of F-actin (Karpova et al, 1995). This data indicates roles 
of capping proteins in stabilising F-actin structures.
1.5.5 Actin Bundling Proteins.
Actin bundling proteins are abundant throughout the eukaryotic kingdom and examples 
include fimbrin, a-actinin and spectrin (for review see Dubreuil, 1991). Each of these 
proteins contain at least one actin-filament binding domain, composed of two Calponin 
Homology (CH) domains. These actin-binding domains all display a similar structure, 
however the length and flexibility of the spacer sequences separating the actin binding 
domains is different in each of these proteins (Figure 1.4) (Dubreuil, 1991). These 
differences determine the different properties of these actin-bundling proteins. Budding 
yeast contain just one known actin bundling protein Sac6p (yeast fimbrin). Cells lacking 
SAC6 contain abnormal actin structures, are defective in cell morphogenesis and also 
endocytosis (Adams et at, 1991; Singer-Kruger and Ferro-Novick, 1997). This suggests 
that actin bundling proteins serve to strengthen the actively growing regions of cells.
11
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1.5.6 Myosins.
All of the actin filament motor proteins identified to date belong to the myosin family. 
Myosins contain a conserved motor domain but other domains vary from myosin to myosin 
and determine the specific role of the molecule in the cell. Myosins can be divided into 
different subfamilies, the most abundant being the myosin II subfamily. Members of this 
subfamily contain two motor head domains and a long rod shaped tail. Each of these two 
head domains possesses an ATPase and a motor activity. Smaller myosins are also found 
throughout evolution, the best characterised being the myosin I subfamily. These smaller 
myosins are thought to be primitive myosins from which the myosin II subfamily has 
evolved.
Budding yeast contain five different myosins that have been demonstrated to fulfil and 
variety of cellular roles. Myo3p and Myo5p are class I myosins that are involved in the 
organisation of the actin cytoskeleton (Goodson et al, 1996; Lechler et al, 2000). Both 
Myo3p and Myo5p have been reported to interact with Lasl7p and the Arp2/3p complex 
(Evangelista et al, 2000; Lechler et al, 2000). This may allow these myosins to spatially 
and temporally regulate the processes of actin dynamics and vesicle transport in yeast cells. 
Myolp belongs to the class II myosins and has been demonstrated to play roles in 
maintaining the cell structure (Brown, 1997) and cytokinesis (Lippincott and Li, 1998). 
Myo2p and Myo4p are class V myosins and are involved in vesicle transport (Mazzoni et 
al, 1993) and cell polarity (Santos etal, 1997; Long etal, 1997).
1.5.7 Differences between yeast and mammalian actin-binding proteins.
Although yeast cells contain many actin-binding proteins that have homologues in 
mammalian cells, they do not contain homologues of every mammalian actin binding 
protein. For example budding yeast cells contain no known proteins possessing a gel
13
forming activity similar to that of a-actinin found in mammalian cells, a-actinin belongs to 
a family of proteins possessing CH (Calponin Homology) domains (Figure 1.4) (Dubreuil, 
1991). Budding yeast contain three actin-binding proteins belonging to this family (Sac6p, 
Sep Ip and IQGAP). However mammalian cells display a much wider variety of proteins 
containing these domains. This may represent the ancestery of this family in that yeast 
cells contain the earliest forms of this family and mammalian cells have evolved a wider 
number of proteins belonging to this family.
1.6 Actin cytoskeleton disrupting drugs.
The actions of the actin-cy to skeleton modifying drugs Latrunculin-A (LAT-A) and 
cytochalasin-D and phalloidin have been elucidated. Actin cytoskeleton disrupting drugs 
have been useful in allowing researchers to disrupt the normal functions of actin and 
examine the consequences.
1.6.1 Phalloidin.
Phalloidin is an example of a dmg that stabilises actin filaments. It has been shown to bind 
actin filaments more tightly than actin monomers (Estes et al, 1981) preventing actin 
filament depolymerisation and shifting the equilibrium from monomer toward filament by 
lowering the critical concentration for polymerisation by 10 to 30 fold (Estes et al, 1981; 
Faulstich et al, 1977). Phalloidin has proved a useful tool in fluorescence microscopy, 
when coupled to a fluorescent molecule it allows visualisation of a cells actin cytoskeleton 
(Adams and Pringle, 1991).
1.6.2 Latrunculin-A (LAT-A).
LAT-A is an actin cytoskeleton-disrupting drug that sequesters actin monomers and 
prevents them from taking part in the rapid cycles of actin assembly/disassembly
14
(Ayscough et al, 1997). The effects of LAT-A are rapid and reversible making it a useful 
laboratory tool. LAT-A has recently been shown to alter the actin-monomer subunit 
interface preventing its polymerisation into F-actin structures (Morton et al, 2000). LAT-A 
is capable of disrupting the yeast actin cytoskeleton and has allowed researchers to study 
the yeast actin cytoskeleton in vivo (Ayscough et al, 1997).
1.6.3 Cytochalasin-D.
Cytochalasin-D is thought to have multiple effects on actin but overall also results in F- 
actin disruption (for review see Cooper, 1987). One effect that has been deteimined is that 
cytochalasin-D binds to the barbed end of actin filaments in a similar way to capping 
proteins (Flanagan and Lin, 1980; Brown and Spudich, 1981). Binding of cytochalasin-D 
to actin filaments inhibits both association and disassociation of actin monomers from the 
barbed end (Flanagan and Lin, 1980; Brown and Spudich, 1981). Cytochalasin-D also 
binds to actin monomers. Studies have shown that this drug increases the rate of 
spontaneous actin polymerisation (Tellam and Frieden, 1982) and to increases the rate of 
ATP hydrolysis by actin monomers (Brenner and Korn, 1981).
1.7 Nucléation of actin polymerisation.
Actin polymerisation requires nucléation either by generating an actin trimer or from the 
end of an existing filament. Formation of the actin trimer is the rate-limiting step in actin 
polymerisation (Cooper et al, 1983). The Arp2/3 complex has emerged as a strong 
candidate for nucleating actin filament assembly (Figure 1.5). The Arp2/3 complex 
consists of seven subunits, two of which are the actin related proteins (Arp) Arp2p and 
Arp3p. Much of our understanding of this complex has been focused on Arp2p and Arp3p. 
As both of these proteins are structurally similar to actin, the Arp2/3 complex is structurally 
well suited to serve as an actin filament nucleator (Kelleher et al, 1995). Through
15
(B). Nucléation
Plasma membrane
T J (A). Targeting and Activation
t  f
c /  \
Arp2/3 complex
Side-binding
(C). Branching
Figure 1.5 Arp2/3 complex binds to the sides of actin filaments, nucleating actin 
polymerisation and forming a branched actin filament network. (A) The Aip2/3 
complex is targeted to and activated at sites of new actin polymerisation. The Wiscott- 
Aldrich syndrome protein (WASP) family proteins, that bind directly to the Arp2/3 
complex, are strong candidates for activators. (B) Once in place the Arp2/3 complex 
initiates nucléation of new actin filaments. (C). The Arp2/3 complex can also bind to 
the sides of existing filaments to cause side branching resulting in a branched actin 
filament network. Adapted from Machesky and Gould, 1999.
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structural modelling, it has been predicted that at the barbed end an Arp2p/Arp3p 
heterodimer interacts with the pointed end of actin molecules to nucleate filament growth 
toward the barbed end (Kelleher et al, 1995).
The Arp2/3 complex has been proposed to mimic the fast growing barbed end of an actin 
filament allowing the Arp2/3 complex to nucleate actin assembly, cap the slow growing 
end and cross-linking actin filaments (Mullins et al, 1998). This method of actin nucléation 
produces a branched actin network at regions of rapid actin dynamics (Mullins et al, 1997), 
for example at the leading edge of motile cells or cortical actin patches in budding yeast 
(Figure 1.5).
Sequence identification of the subunits of the Arp2/3 complex has demonstrated that they 
are highly conserved throughout eukaryotic cells (Welch et al, 1997). Yeast serves as an 
excellent genetic system to study the in vivo function of the Arp2/3 complex. In budding 
yeast, Arp2p and Arp3p are components of cortical actin patches (Moreau et al, 1996; 
Winter et al, 1997). Both Arp2p and Arp3p function to maintain the proper organisation of 
the cortical actin cytoskeleton and Arp3p is required for actin patch motility (Moreau et al, 
1996; Winter et al, 1997).
1.8 Activation of the Arp2/3 complex by the Wiscott-Aldrich syndrom 
protein family.
Purified Arp2/3 complex only weakly activates actin nucléation. However this activity is 
dramatically enhanced by the addition of WASP (Wiscott-Aldrich syndrom protein) family 
proteins (Machesky and Insall, 1998). WASP family proteins share several different 
functional domains (Figure 1.6). WASP homology domain 1 (WHl), an N-terminal domain
17
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that contains sequence homology to pleckstrin homology (PH) domains, has been shown to 
interact with phospholipids in vitro (Miki et al, 1996; Imai et al, 1999). Both WASP and 
N-WASP contain a GTPase binding domain that interacts with Cdc42p (Kolluri et al, 1996; 
Symons et al, 1996), a small GTP binding protein that is involved in regulation of actin 
cytoskeleton rearrangements (for review see Nobes and Hall, 1995).
Downstream of the WASP GTPase binding domain exists a proline rich region that 
interacts with the SH3 domains of several signalling proteins (Miki et al, 1996). Towards 
the C-terminus of the protein exists a V domain that binds to G-actin and a CA domain that 
interacts with the Arp2/3 comlex (Miki and Takenawa, 1998; Machesky et al, 1999;
Rohatgi et al, 1999). The presence of different functional regions of WASP family proteins 
suggests that it functions as a molecular scaffold that links various signalling pathways to 
actin dynamics. The yeast WASP-like protein Lasl7p/Beelp (Li, 1997) contains all the 
functional regions mentioned above except for the GTPase binding domain that interacts 
with Cdc42p (Symons et al, 1996).
The C-terminal region of WASP family members enhances the nucléation activity of the 
Arp2/3 complex (Machesky et al, 1999). Lasl7p has been demonstrated to interact with 
the Arp2/3 complex, and the acidic domain of Lasl7p is necessary for this association. 
Lasl7p also stimulates the nucleating activity of the Arp2/3 complex in vitro and both the 
V and acidic domains are required for the optimal stimulation of the Arp2/3 complex 
(Winter et al. 1999).
1.9 Identification of SLAl,
One of the first actin binding proteins identified in yeast was Actin Binding Protein-1 
(Abplp). Abplp was identified as an actin binding protein by affinity chromatography
19
(Drubin et al, 1988). It was localised to the cortical actin patches of yeast cells, and its 
overexpression was shown to depolarise the cortical actin cytoskeleton. Deletion of ABPl 
had no obvious phenotype indicating functional redundancy exists between Abplp and 
other unknown yeast proteins.
Recent work has however demonstrated that Abplp interacts with and stimulates the 
nucleating activity of the Arp2/3p complex in yeast cells (Goode et al, 2001). Abplp 
contains two acidic sequences that are required for activation of the Arp2/3p complex in 
vitro (Goode et al, 2001). The mammalian homologue of Abplp, mAbpl, has been 
demonstrated, by coimmunoprecipitation and colocalisation, to interact with dynamin in 
vivo (Kessels et al, 2001). This may suggest that Abplp links the actin cytoskeleton to 
endocytosis (Kessels et al, 2001).
To gain more of an insight into the function of Abplp a synthetic lethal screen was 
performed to identify mutations that caused cells to become dependent on the expression of 
functional Abplp for viability (Holtzman et al, 1993). Three genes were identified as being 
essential in cells lacking functional Abplp. These were SLAl (Synthetic Lethal with 
ABPl-l), SLA2 and SAC6 (yeast fimbrin).
Slalp contains an interesting set of structural characteristics (Figure 1.7). Three Src 
Homology-3 (SH3) domains are located in its N-terminal third (Figure). In a variety of 
organisms SH3 domains have been shown to mediate protein-protein interactions between 
signalling and cytoskeletal proteins (Ren et al, 1993; Yu et al, 1994). Its central region 
contains two domains that share the highest level of sequence conservation between Slalp 
and its S.pombe homologue (Holtzman et al, 1993; Ayscough et al, 1999), and its C-
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terminal third is comprised of repeat motifs with an approximate consensus 
LxxQxTGGxxxPQ (Holtzman et al, 1993; Ayscough et al, 1999).
1.10 Phenotypes of Aslal cells.
Deletion of SLAl caused cells to become temperature sensitive, have an aberrant cortical 
actin cytoskeleton organisation and to depend on the expression of ABPl (Holtzman et al, 
1993), More recent studies have shown that the region of Slalp required for normal actin 
organisation is different from the region required to rescue the Abplp dependent phenotype 
(Ayscough et al, 1999).
Studies using plasmid borne domain deletions of SLAl revealed that Slalp lacking 
approximately two thirds of its C-terminal repeat region contained a relatively normal 
cortical actin cytoskeleton organisation but cells required the expression of ABPL Cells 
expressing SLAl lacking the GAP1+SH3#3 region (Figure 1,7) had an aberrant cortical 
actin cytoskeleton organisation but were viable in the absence of functional ABPl 
(Ayscough et al, 1999). These data suggest that Slalp has more than one function and that 
these are attributable to separable domains.
1.11 Interactions of Slalp.
Slalp has been reported to interact with an increasing number of proteins. These 
interactions have been determined by a number of approaches including genetic, 2-hybrid 
and coimmunoprecipitation. Most of these proteins can be divided into two groups, either 
they are actin binding proteins or proteins involved in endocytosis. This section will 
concentrate on the reported physical interactions of Slalp.
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1.11.1 Interactions with actin binding proteins.
It has been demonstrated, by immunoprécipitation and GST pull-downs, that Lasl7p and 
Abplp interact with Slalp (Li, 1997; Warren et al, in press). Also during the course of 
these studies, others in the Ayscough lab demonstrated that Sla2p interacts with the 
GAP1+SH3#3 region of Slalp in the yeast 2-hybrid system (Gourlay et al, submitted).
This interaction was shown to be direct using purified proteins in vitro (Gourlay et al, 
submitted).
SLA2 is a nonessential gene that is required for the organisation of the yeast cortical actin 
cytoskeleton, growth at higher temperatures, cell morphogenesis (Holtzman et al, 1993) 
and the internalisation step of endocytosis (Raths et al, 1993; Wesp et al, 1997). All Sla2p- 
related proteins share a similar arrangement of three predicted coiled-coil domains, a 
proline rich region and a C-terminal talin homology domain. Talin is a protein found in 
focal adhesion plaques and the talin-homology domain of Sla2p has been shown to bind 
aetin in vitro (McCann and Craig, 1997). The central coiled-coil domain of Sla2p has an 
endocytic function that is redundant with the function of Abplp (Wesp et al, 1997).
1.11.2 Interactions with components of the endocytic machinery.
The C-terminal repeat region of Slalp has been shown by yeast 2-hybrid and 
immunoprécipitation to interact with the Panlp/End3p complex (Tang et al, 2000). The 
Slalp/Panlp/End3p trimeric complex (Figure 1.8) is proposed to function in the process of 
endocytosis (Tang and Cai, 2000). Pan Ip and End3p are yeast proteins that contain Epsin 
Homology (EH) domains. EH domains are protein-protein interaction modules and have 
been shown to interact with the NPFxD motif (Slacini et al, 1997), a motif involved in 
ubiquitin-independent endocytosis (Tan et al, 1996; Wendland et al, 1998). Both Pan Ip
23
and End3p also participate in the regulation of the cortical actin cytoskeleton (Benedetti et 
al, 1994, Tang and Cai, 1996, Tang etal, 1997).
Pan Ip contains two long repeats (LRl and LR2) in its N-terminal region, each containing 
an EH domain and multiple copies of the LxxQxTG repeat that are also present in the C- 
terminal repeat region of Slalp. The LR2 region of Pan Ip is essential for viability and has 
been shown to interact with End3p (Tang et al, 1997). End3p contains an EH domain in its 
N-terminal region and two sets of C-terminal repeats. (Benedetti et a/,1993; Raths et al, 
1993). Others had demonstrated an interaction between the LR2 region of Pan Ip and the 
C-terminal repeat region of End3p (Figure 1.8) before we began this work (Tang et al, 
1997). During the course of these studies Slalp was shown to interact with the LRl region 
of Pan Ip and the EH domain of End3p via its C-terminal repeat region (Tang et al, 2000).
In addition, other studies demonstrated Pan Ip has been shown to contain motifs that are 
phosphorylated by Prklp and Arklp. These studies demonstrated that Prklp 
phosphorylates the LxxQxTG motifs present in LRl and LR2 of Pan Ip. Binding of End3p 
to Pan Ip prevented the phosphorylation of Pan Ip by Prklp (Zeng and Cai, 1999). Slalp 
contains 5 of these LxxQxTG repeats and also a further 9 repeats with the QxTG consensus 
within its C-terminal repeat region and studies in vitro using these Slalp repeats fused to 
GST revealed they were a good substrate for Prklp (Tang et al, 2000).
1.12 Roles for actin dynamics in membrane trafficking
One of the most obvious phenotypes when yeast actin-binding proteins are mutated is that 
cells become large and round, suggesting that membrane trafficking is defective when the 
actin cytoskeleton is disrupted. The first evidence for this arose from studies using 
conditional actin mutants that displayed a partial defect in the secretion of invertase 
(Novick and Botstein, 1985). Further evidence was demonstrated from studies using
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mutants affecting either actin cytoskeleton components or regulators of actin cytoskeletal 
polarity. For example mutations in either Cdc42p, its exchange factor Cdc24p or the actin 
binding protein Sac6p resulted in cells that displayed reduced polarity of the actin 
cytoskeleton and showed inappropriate growth of the mother cells resulting in abnormally 
large cells (Sloat and Pringle, 1978; Adams et al\ 1990; Adams et al, 1990). Fimbrin has 
also been demonstrated to be required for endocytosis in yeast cells, implicating the actin 
cytoskeleton in endocytosis as well as exocytosis (Kubler and Riezman, 1993).
Clathrin-dependent receptor mediated endocytosis is the best characterised endocytic 
pathway in both yeast and mammalian cells. In this pathway, plasma membrane-localised 
receptors bind to their ligand and then associate with the heterotetrameric adaptor complex 
AP-2. AP-2 recruits and polymerises clathrin, ultimately leading to the formation of 
clathrin coated vesicles. These vesicles are then uncoated and the adaptors and clathrin are 
recycled. The uncoated vesicle then enters the early endosome (for review see Schmid, 
1997).
Several functional roles for actin in the endocytic process have been proposed (Figure 1.9). 
The actin cytoskeleton might provide a force allowing vesicles to bud or mediate vesicle 
transport or fusion events (Lamaze et al, 1997; Merrifield et al, 1999). Alternatively the 
actin cytoskeleton may provide a scaffold at the plasma membrane for the endocytic 
machinery (Wendland et al, 1998; Gaidarov et al, 1999). Evidence suggests that 
endocytosis is closely linked to and is dependent upon actin dynamics. Treatment of cells 
with the actin monomer monomer sequestering drug LAT-A depoly merises the actin 
cytoskeleton and inhibits receptor mediated endocytosis in both yeast (Ayscough and 
Drubin, 1998) and mammalian cells (Lamaze et al, 1997). Mutations in a large number of
26
(A).
(B).
(C).
(D).
Figure 1.9
Potential roles for the actin 
cytoskeleton in endocytosis. 
(A) The vesicle budding site 
may be marked by proteins 
attached to filamentous 
actin allowing endocytosis 
to begin. Cytoskeletal 
structures may act as a 
scaffold for the endocytic 
machinery and provides 
support for the deformation 
and invagination of the 
plasma membrane. (C) The 
cortical actin barrier 
underlying the vesicle may 
need to be disassembled and 
actin polymerisation may 
provide force, driving 
membrane fission during 
endocytic vesicle formation.
(D) Actin polymerisation 
may promote the movement 
of the newly formed 
endocytic vesicle into the 
cytoplasm. Adapted from 
Qualmann et al, 2000.
27
yeast cortical actin patch associated proteins, such as Panlp, End3p, Sla2p, also produce 
defects in both endocytosis and cortical actin cytoskeleton organisation.
Many of the mammalian homologues of the actin patch associated proteins have been 
identified to be associated with clathrin coated pits. The mammalian homologue of Sla2p 
is mHIPlp (huntingtin interacting protein-1), Recent studies have demonstrated that 
mHIPlp associates with clathrin coated pits and vesicles (Engqvist-Goldstein et al, 1999). 
mHIPlp has been shown to interact with clathrin and the AP-2 complex, and has been 
proposed to participate in the assembly of the clathrin latice which gradually drives the 
invagination of clathrin coated pits (Waelter et al, 2001).
Epsl5p, the mammalian homologue of Panlp, has also been shown to be associate with 
clathrin coated pits (Benmerah et al, 1995) via an interaction with the AP-2 adaptor 
complex (Delft et al, 1997). More recently, the Eps 15 interaction with AP-2 has been 
shown to be required for assembly of clathrin-coated pits and for endocytosis (Benmerah et 
al, 1998; 1999). As mentioned earlier the mammalian homologue of Abplp, mAbpl, has 
been reported to interact with dynamin, a GTPase that functions in endocytosis.
Recent studies have demonstrated that both Panlp and Abplp can interact with, and 
stimulate the nucleating activity of the Arp2/3 complex (Duncan et al, 2001; Goode et al, 
2001). Panlp, Abplp and their mammalian homologues have been demonstrated to 
interact with other proteins involved in endocytosis. This would suggest that endocytosis is 
directly linked to actin dynamics in yeast and that disruption of the actin cytoskeleton also 
disrupts endocytosis. This is supported by the observations that mutants of cortical actin 
patch components disrupt both endocytosis and the cortical actin cytoskeleton.
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1.13 Aims of this project.
Slalp is required for proper organisation of the cortical actin patches. Previous studies 
using a plasmid borne SLAl mutant lacking approximately two thirds of the C-terminal 
repeat region demonstrated that this region was required to rescue the Abp 1 p-dependent 
phenotype associated with the SLAl knockout. To further characterise the roles and 
interactions of the C-terminal repeat region of Slap, we constructed yeast strains expressing 
SLAl that is lacking the entire C-terminal repeat region.
During the course of this work, the C-terminal repeat region of Slalp was shown to contain 
motifs that are a potential target for the Actin Regulating Kinases Arklp and Prklp (Tang 
et al, 2000). These kinases could therefore potentially regulate the functions of Slalp 
within cells. This project aimed to further our understanding of the possible regulation of 
Slalp function, and its roles in regulating both organisation of the actin cytoskeleton and 
endocytosis at the cell cortex.
The final aim of this project was to identify interacting partners for the central region of 
Slalp, using the yeast 2-hybrid system. To date little is known about this region of Slalp 
even though it contains the two highest regions of sequence similarity between the known 
homologues of Slalp. This may help us to elucidate further the functions of Slalp and 
could shed light on how Slalp functions are conserved through evolution.
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Chapter 2. 
Materials and Methods.
2.1 Materials.
All chemicals used in this study were obtained from BDH/Merck or Sigma unless over­
wise stated.
2.2 Yeast Strains, Plasmids and Oligonucleotides.
All yeast strains, plasmids and oligonucleotides generated and used during the course of 
this study are listed in tables 2.1, 2.2 and 2.3 respectively.
2.3 Molecular Biology Techniques.
2.3.1 Restriction enzyme digestion of DNA.
All enzymes used in this study were from New England Biolabs and digests were carried 
out according to the manufacturer’s instructions, using the buffers supplied. Digests were 
typically performed in a final volume of 20 /xl, using 1-2 U of enzyme per 10 /xl reaction. 
When performing double digests where enzymes required similar conditions, the DNA was 
digested simultaneously with both enzymes according to the manufacturer’s instructions. 
Most digests were carried out at 37°C for 3 hours unless otherwise recommended by the 
manufacturer.
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Table 2.1 Yeast strains used.
KAY Genotype
302 MATa, trpl-1, leu2-3,112, lys2-801, his3-A200, ura3-52
300 MATa, trpl-1, leu2-3,112, his3-A200, ura3-52, 
Aslal::URA3
301 MATa, trpl-1, leu2-3,112, his3-A200, ura3-52, 
Aslal::URA3
303 KAY302 + SLAl-9xmyc::TRPl
369 KAY302 + slalACt::TRPl
370 MATa, trpl-1, leu2-3,112, lys2-801, his3-A200, ura3-52, 
slalACt::TRP
363 KAY302 + slalACt-9xmyc::TRPl
364 KAY302 + slalACt-3xHA::TRPl
397 KAY302 + SLA1-GFP::HIS3
476 KAY303 + END3-3xHA::HIS3
355 KAY302 + SLAl-3xHA::TRPl
116 MATa, leu2-3,112, his3A200, ura3-52, barl
117 KAY 116 + integrated end3 -1
462 MATa, end3-l, leu2-3,112, his3A200, ura3-52, 
SLA1-GFP::HIS3
Origin.
DDY852 
Ayscough et al, 
1999
Ayscough et al, 
1999
Ayscough et al, 
1999
Warren et al,
In press 
This study
Warren et al.
In press 
This study 
This study 
This study 
This study 
Benedetti et al, 
1994
Benedetti et al, 
1994
Warren et al.
In press
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599 KAY302 + Aabpl ::HIS3 This study
600 KAY599 + pKAl 1 This study
406 KAY600 + slalACt::TRPl This study
376 MATa, leu2-3,112, his3A200, ura3~52, lys2-801, Cope et al, 2000
Aarkl::HIS3
381 MATa, leu2-3,112, his3A200, um3-52, lys2-801, Cope et al, 2000
Aprkl::LEU2
463 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801, This study
Aarkl::HlS3
464 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801, This study
Aprkl::LEU2
456 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801, This study
Aarkl::HIS3, Aprkl::LEU2
393 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801, This study
Aarkl::HIS3, SLAl-9xmyc::TRPl
394 MATa, trpl-1, leu2-3,112, his3A200, ura3-51, lys2-801. This study
Aprkl::LEU2, SLAl-9xmyc;:TRPl
405 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801. This study
Aarkl::HIS3, Aprkl : :LEU2, SLAl-9xmyc: :TRP
465 KAY405 + pJC232 (pEG-KT + PRKl) This study
466 KAY405 + pJC233 (pEG-KT + Kinase dead prkl) This study
467 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801, This study
Aarkl::HIS3, slalACt::TRPl
468 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801. This study
Aprkl::LEU2, slalACt::TRPl
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469 MATa, trpl-1, leu2-3,112, his3A200, ura3-52, lys2-801,
Aarkl::HIS3, Aprkl ::LEU2
455 MATa, ade2-l, his3-ll, leu2~3,112, trpl-1, ura3-l canl-100, 
ssdl-d2, GAL+
460 KAY455 + glc7::LEU2, trpl::glc7-13:;TRPl
438 MATa, trpl-901, leu2-3,112, ura3-52, his3-200, gal4A,
gctl80A,, L Y S 2 ' , ' G A L l ( j ^ ^ - G A L l G A L 2 u^ ^-GAL2y^ j^  
-ADE2
581 KAY438 + pDWl
582 KAY581+pKA
568 KAY438 + pKA + pKA
480 MATa/a, his3Al/his3Al, leu2Al/leu2Al, ura3A/ura3A,
metl5/MET15, LYS2Ays2A.
447 MATa, his3-l, leu2Al, ura3A, metlS, LYS2
479 KAY480 + Aycl034w::Kanmx/Aycl034w::Kanmx
465 MATa, his3Al, leu2Al, ura3A, Aycl034w::Kanmx
515 MATa, his3Al, leu2Al, ura3A, Aycl034w::Kanmx
510.1 KAY3Q2 + Ay sc84::HIS3
516 MATa, his3A, leu2A, ura3A, Aycl023w::Kanmx, Aysc84::HIS3
126 MATa, his3-A200, leu2-3,112, ura3-52, Aabpl::LEU2
406 MATa, his3-A200, leu2-3,112, ura3-52, Aabpl ::LEU2
466 MATa , his3A, leu2A, ura3A, Aycl034w::Kanmx, Aabpl ::LEU2
467 MATa , his3A, leu2A, ura3A, Aycl034w::Kanmx, Aslal::URA3
This study
W303
James et al,
1996
This study 
This study 
This study 
Research (RG) 
Genetics B4743 
RGBY4742 
RG 33441 
This study 
This study 
Hilary Dewar, 
unpublished data 
This study 
Ayscough et al,
1997 
DDY322 
This study 
This study
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111 MATa, ura3-52, lys2-801, ade2-101, trpl-A63, his3-A200, 
Ieu2-Al, fu s l LACZ::URA3.
DK499
316 K A Y i n  + STE2-9xmyc::TRPl. Wan en et û 
In press
391 YLAY316 + Aslal::URA3. Wanen et a 
In press
yDW Genotype Origin
83 KAY581 + pGAD-YCL034w insert This study
104 KAY581 + pGAD-YCL034w insert This study
106 KAY581 + pGAD-YCL034w insert This study
107 KAY581 + ÿGAD-YCL034w insert This study
108 KAY581 + pGAD-FCL034W insert This study
110 KAY581 + pGAD-YCL034w insert This study
109 KAY581 + pGAD-F^CS^ fragment This study
101 KAY581 + pGAD-YDR128w fragment This study
88 KAY581 + pGAD-YNR065c fragment This study
39 KAY581 + pGAD~YNR065c fragment This study
97 KAY581 + pGAD-ZRT3 fragment This study
100 KAY581 + pGAD-ZRTJ fragment This study
111 KAY581+ pGAD“ YPRl 71 w fragment This study
38 KAY581 + pGAD-AZ)/7 fragment This study
60 KAY581 + pGAD~ADH fragment This study
82 KAY581 + pGAD-AT>/7 fragment This study
99 KAY581 + pGAD-AZ)77 fragment This study
102 KAY581 + pGAD-AZ)^ fragment This study
34
58 KAY581+pGAD“GAL4 fragment This study
59 KAY581 + pGAD-GAL4 fragment This study
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Table 2.2 Oligonucleotides used in these studies.
oKA Sequence Description
13 CATTATTGGGACTGAGAACG SLAl-tag C-terminal check (5’)
14 CCATTGGATCCATTCAAAACC SLAl-tag C-terminal check (3’)
407TGCTGCTCCGGTTTCATCTGCTCCGGTTTC Tagging and deleting C-
ATCTGCTCCCGCTCCATTGGATCCATTCAA terminal repeats of S lA l  (5’) 
TCCGGTTCTGCTGCTAG 
408GTAATCATTGGCATCATCACAAAGCCAGTA Tagging and deleting C-
GATAAGGGTAAGATATTGTTGCCACCGGTT terminal repeats of 5 M 7 (3’) 
CCTCGAGGCCAGAAGAC
83 GCTTGGACTGTTAAACCGGC slalACt-tag::TRPl (5’) check
84 GTGGCAATTGGTATTAGGCC slalACt-tag::TRPl (3’) check
112ATCTATAAACAAACAATCGCATAACCGCAC Aabpl::HIS3 (5’)
GTATATACACGCACACACCTATCAATCACA 
CGGATCCCCGGGTTAATTA 
113TACAAAAGCTTTAACGTCTCTGTAAGTATTT Aabpl::HIS3 (3’) 
TTTTACGTAAGAATAATATAATAGCATGAGA 
ATTCGAGCTCGTTTAAA
130 ACCATTGATGTATTTCTGTA Aabpl::HlS3 5^  check
131 ACCATTGATGTATTTCTGTA Aabpl::HIS3 3’ check
148 CGTGCAAGATTCCGAATACCG 5’ YEpl3 sequencing
152 ATATAGGCGCCAGCAACCGCA 3’ YEpl3 sequencing
153 ATACCACTACAATGGATGATG pGAD (5’) sequencing
154 AGATGGGCATTAATTCTAGTC pGAD (3’) sequencing
182 ACATCATCATCGGAAGAGAG pGBD (5’) sequencing
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oKA Sequence
183 AATGAAAGA AATTGAGATGG
184 CGTCGTGGATCCGACCAAAGATTTCCCCAA
185 CGTCGTCTGC AGGACCC ATCATTCGCCTTA 
456CACGAATTGCAAGCATTACAAGCAGAAAT
CAATGCTGCAGCCGCTGCAGCTGCACGGA
TCCCCGGGTTAATTAA
457GTGAAATAACAAACAGTAAATATTACACA
TTCATGTACATAAAATTAATTATCGGAATT
CGACCTCGTTTAAAC
204 GAGTTCCGATAGCAGTGGCAG
205 GTATACACCACACCGTTACTG
111 ACGATCTCA AACCCTTTCGGTGATCATAA 
CAAAGCTGCAGCCGCTGCAGCTGCACGG 
ATCCCCGGGTTAATTAA
112 GGATTAAATGTACTATATATATATATATAT 
ATATGTGTGTATGCATACGTACATACTGAA 
TTCGAGGTTTAAAC
226 CCAGGCAAGGGCGATCAGAAG
227 CTGGAGCCATCACATATCATC
Description
pGBD (3’) sequencing 
SLAI HD1-HD2 region (5’) 
SLAJ HD1-HD2 region (3’) 
HA tagging ENDS (5’)
HA tagging ENDS (3’)
END3-HA (5’) check 
END3-HA (33 check 
Tagging YCL034w + 7xAla 
linker (5’)
Tagging YCL034w (3’)
YCL034w-tag (5’) check 
YCL034w-tag (3’) check
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Table 2.3 Plasmids used in these studies.
Plasmid Description Origin
pWZV86 For TRPl marked gene deletions K. Nasmyth
pWZV87 For C-terminal 9xmyc tagging 
{TRPl marked)
K. Nasmyth
pWZV89 For C-terminal 3xHA tagging 
{TRPl marked)
K. Nasmyth
pFA6-7//5JMx6 For HIS3 marked gene deletions Longtine et al, 
1998
p¥K6-3xHA-HIS3MK6 For C-terminal 3xHA tagging Longtine et al.
{HIS3 marked) 1998
pFA6-13xmyc-TRPl For C-terminal 13xmyc tagging Longtine et al
{TRPl marked) 1998
pGBDU-C3 2-hybrid binding domain plasmid James et al, 
1996
pGADU-Cl 2-hybrid activation domain plasmid James et al, 
1996
pDWl pGBDU-C3 + HD1-HD2 region of SLAI This study
pDW38 pGAD + ADH  fragment This study
pDW39 pGAD + YNR065c fragment This study
pDW58 pGAD + GAL4 fragment This study
pDW59 pGAD + GAL4 fragment This study
pDW60 pGAD + ADH  fragment This study
pDW82 pG AD + ADH fragment This study
pDW83 pGAD + YCL034w fragment This study
pDW88 pGAD + YNR065c fragment This study
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pDW97 pGAD + ZRT3 fragment This study
pDW99 pGAD + ADH fragment This study
pDWlOO pGAD + ZRT3 fragment This study
pDWlOl pGAD + YDR128w fragment This study
pDW102 pGAD + ADH fragment This study
pDW104 pGAD + YCL034w fragment This study
pDW106 pGAD + YCL034w fragment This study
pDW107 pGAD + YCL034w fragment This study
pDWlOS pGAD + YCL034w fragment This study
pDW109 pGAD + YSC84 fragment This study
pDWllO pGAD + YCL034w fragment This study
p D W n i pGAD + YPRl 71 w fragment This study
pJC232 pEG-KT + PRKl Cope et al, 1999
pJC233 pEG-KT + Kinase dead prkl Cope et al, 1999
pKAl pRS3l6 +SLAI Ayscough et al, 
1999
pK A ll pRS316+ABP7 Ayscough et al, 
1999
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2.3.2 Removal of the terminal 5' phosphate groups using calf intestinal 
alkaline phosphatase (C.I.P.).
A ninth volume of 10 X C.I.P. Buffer (NEB) and 0.5 U of C.I.P. were added to the digest. 
Samples were incubated at 37°C for 30 minutes and then run on an agarose gel and were 
purified as described in following sections.
2.3.3 Extraction of DNA from an Agarose Gel.
Extraction of DNA from agarose gels was performed using a QIAEXII kit’^  ^(QIAGEN). 
The DNA to be extracted was run on a 0.8% agarose gel (see section 2.2.6) and viewed by 
illuminating the gel with a UV source. The DNA band was cut out of the gel, and the gel 
slice was placed in a 1.5 ml microfuge tube. 3 volumes of Buffer QXl™  to 1 volume of 
gel slice was added to the tube along with 10 /d of resuspended QIAEXII™, Tubes were 
incubated at 50°C for 10 minutes to solubilise the agarose and allows the QIAEX 11^  ^
particles to bind the DNA. The sample was then centrifuged at top speed in a bench top 
microfuge for 30 seconds and the supernatant was carefully removed with a pipette. The 
pellet was washed once with 500 /xl of Buffer QXl™ and twice with 500 jul of Buffer PE. 
Tubes were centrifuged at top speed in a bench top microfuge for 30 seconds after each 
wash. The pellet was then air-dried for 15 minutes, DNA was eluted from the QIAEX IF ^  
particles by resuspending the pellet in 20 pi of sterile water and incubating at room 
temperature for 5 minutes. Tubes were centrifuged for 30 seconds and the supernatant was 
placed in a fresh microfuge tube and stored at -20°C until required.
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DNA ligation.
DNA ligation was performed using a Rapid DNA ligation kit (Roche Diagnostics). DNA 
was diluted 1:5 in DNA Dilution Buffer. 10 /xl of 2 X DNA Ligase Buffer was added along 
with 1 jLtl of DNA Ligase. The contents were mixed well and incubated at room 
temperature for 5 minutes. Tubes were stored at -20°C until required for transformation 
into bacterial cells.
2.3.5 Amplification of DNA using the polymerase chain reaction.
The polymerase chain reaction (PCR) is a method used to amplify specific DNA fragments 
using specific oligonucleotide primers complementary in sequence to the regions flanking 
the sequence of interest. PCR was used on several occasions during this project, the 
method described here was a general PCR method used to amplify sequences from 
plasmids designed to allow deletion or tagging of genes within the yeast genome.
All PCR carried out during this study was achieved using the Bioline reagents. For each 
PCR reaction the following were mixed in 0.5 ml microfuge tubes: 1 juM primer 1, 1 pM 
primer 2, 200 nM dNTP’s, 1 X Tag reaction buffer, 1.5 mM MgCl^, 1 jul template DNA and 
water to 99.5 jul. The components were mixed gently and microfuged briefly then 5 U of 
Tag polymerase was added to each reaction individually. The PCR occurred over 30 cycles 
of amplification in a MWG Biotech Primus PCR machine, each involving steps of 94°C (1 
minute), 52°C (2 minute), 72°C (2 minutes). A final elongation step was used at the end of 
the amplification cycles by incubating at 72°C for 5 minutes. The resulting product was 
electrophoresed on an agarose gel to check that the amplification had worked.
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2.3.6 Electrophoresis of DNA using agarose gels.
DNA fragments were routinely separated and visualised using flat bed agarose gel 
electrophoresis. Typically a 0.8% of the agarose in 1 x TAE (10 mM Tris-HCl pH 7.5, 1 
mM EDTA pH7.5) solution was used but the percentage could be varied to bias separation 
of smaller or larger band fragments. An agarose gel was made by melting the agarose 
solution and allowing it to cool to about 50°C. 50 ml of this solution was then decanted 
into a falcon tube and 2 jttl of a 5 mg/ml stock of ethidium bromide was added. The 
solution was then poured into a casting tray containing a comb with the required number of 
teeth. After the gel had set, the DNA was mixed with 6 x gel loading buffer (0.25% 
Bromophenol Blue, 0.25% Xylene Cyanol FF, 30% glycerol in water) and then loaded into 
the wells of the gel. Samples were electrophoresed in 1 x TAE at between 80 and 120 V 
until the bromophenol blue of the loading buffer was at the bottom of the gel. The DNA 
was then visualised by illuminating the gel with an UV light source.
2.3.7 Bacterial media.
2xYT 1.6% tryptone 
1 % yeast extract 
0.5% NaCl
Supplement with 2% agar for solid media.
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M9 media 0.675% Na2ÏîP04 
0.3% KH2PO4 
0.1% ammonium chloride 
0.05% NaCl 
0.035% do leucine mix 
Supplement with 2% agar for solid media 
Autoclave
Allow to cool to 50°C and then add;
5 mM MgSÛ4 
0.25 mM CaCls 
100 jLtg/ml ampicillin 
2% glucose
2.3.8 Preparation of Calcium Competent DH5a cells.
An overnight culture of DH5a cells was diluted 1:200 into 100 ml of 2xYT liquid.
Cultures were then incubated at 37“C for approximately 2 hours until OD^oo^O.S-O.b. The 
culture was then split into falcon tubes and placed on ice for 10 minutes. Cells were 
harvested by centrifugation in an Heaerus megafuge at 600 g for 5 minutes at 4“C. The 
cells pellet was resuspended in 50 ml of ice cold 100 mM CaClj. Tubes were incubated on 
ice for a further 30 minutes. Cells were again harvested by centrifugation and the cell 
pellet was resuspended in 5 ml CaCl^ + 15% glycerol. 100 fû aliquots were snap frozen in 
liquid nitrogen and stored at -80°C.
2.3.9 Transformation of Calcium Competent DH5a cells.
Calcium competent cells were removed from the -80°C freezer and thawed on ice. 40 /xl of 
cells were placed into a fresh tube and 1 pi of DNA was added. Tubes were incubated on
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ice for 30 minutes and heat shocked at 42°C for 40 seconds. 200 fx\ of 2xYT (1.6% 
tryptone, 1% yeast extract and 0.5% NaCl) was then added to tubes and the culture was 
incubated at 37°C for 1 hour without shaking. Cells were then spread onto plates 
containing the appropriate antibiotic (most usually 100 /tg/ml ampicillin) and incubated 
overnight at 37°C.
2.3.10 Plasmid DNA purification (Miniprep).
Plasmid DNA was purified using the QIAGEN^^^ QIAprep spin kit™. Cells from a 2 ml 
overnight bacterial culture were harvested by centrifugation at top speed in bench top 
microfuge. The cell pellet was resuspended in 250 jul of Buffer PI™  and 250 pi of Buffer 
P2TM was added to tubes. Tubes were then inverted 6 times and incubated at room 
temperature for 5 minutes. 350 pi of Buffer N3™ was added and the tubes were again 
inverted 6 times. Tubes were centrifuged at top speed in a bench top microfuge for 10 
minutes. The supernatant was then poured into a QIAprep spin column'^^ in a 2 ml 
collection tube and then tubes were spun at top speed for 1 minute. The flow through was 
discarded and the QIAprep spin column'^’^  was washed with 750 /xl of Buffer PE and 
centrifuging at top speed in a bench top microfuge for 1 minute. The flow through was 
again discarded and tubes were centrifuged for an additional 1 minute to remove residual 
wash buffer. The QIAprep column^^ was placed in a fresh 1.5 ml microfuge tube and 
DNA was eluted from the column by adding 30 (Û of sterile water, incubating at room 
temperature for 1 minute and centrifuging at top speed for 1 minute.
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2.4 Y east Methods.
2.4.1 Yeast media.
YPAD 1% yeast extract 
2% peptone 
0.002% adenine 
2% glucose
For solid media supplement with 2% agar.
Drop-out media 0.67% nitrogen base without amino acids 
0.2% drop-out mix 
2% glucose
For solid media supplement with 2% agar.
sporulation media 1 % potassium acetate
2% agar
5-FOA media 0.67% nitrogen base (Difco)
0.2% drop-out uracil mix 
2% glucose
0.1% 5-FOA (Melford Laboratories) 
2% agar.
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2.4.2 Mating Yeast Cells.
Cells of the opposite mating type were patched onto each other and allowed to grow at 
30°C for 1-2 days.
2.4.3 Sporulation and Tetrad Analysis.
Diploid strains to be sporulated were grown on YPAD plates overnight at 30°C. Cells were 
patched onto a sporulation plate and incubated at 30°C for up to five days (generally three 
days). The plate was monitored daily to check development of four spored asci. When 
these were plentiful, cells were taken from the plate using a toothpick and were 
resuspended in 100 fi\ filter sterilised 0.1 M potassium phosphate buffer + 0.5 mg/ml lOOT 
zymolyase (ICN Biomedical) and incubated for 10 minutes at room temperature. Once 
digested, spores were struck onto YPAD plates, placed under a micromanipulator (Singer) 
with the needle beneath and facing up toward the cells on the plate. Looking down the eye­
piece of the micromanipulator, the region of spread cells was located and tetrads isolated 
and dissected into rows of four spores on the YPAD plate using the x and y co-ordinates. 
When sufficient spores were isolated the plate was incubated at 30°C until the spores 
germinated and became visible. The number of viable spores was noted and they were 
patched onto YPAD or selective plates to test for genetic markers.
2.4.4 Mating Type Determination.
Mating type was determined by crossing with both tester strains (KAY30 MATa hisl', and 
KAY 31 MATa hisl). Cells were patched onto plates lacking histidine and grown at 30°C 
overnight. Only haploid cells that have mated to form diploid cells were able to grow on 
these plates.
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2.4.5 Halo assay for Latrunculin-A Sensitivity.
A 2 ml culture was grown in YPAD liquid media at 30°C overnight. 2 mis of fresh YPAD 
liquid was inoculated with 10 fû of the overnight culture. 1% agar was melted and cooled 
to 50°C before adding to the liquid cell mix. The mix was immediately poured onto a 
YPAD plate and the agar was allowed to set. Once set, four sterile antibiotic assay discs 
were placed on top of the agar. 10 pi of dilutions from a 50 mM stock of LAT-A (Santa 
Cruz) was added to the discs (0, 1, 2, 5 mM). Plates were incubated for 2 days at 30°C 
until halos were visible in the lawn of cells. Relative sensitivity was calculated by 
measuring the diameter of halo formed and plotting a graph of halo diameter against the 
log [LAT-A]. Halo sizes for a concentration of 12 mM LAT-A were calculated. These 
values were plotted on a graph as a ratio of the wild-type halo size.
2.4.6 Yeast Transformations.
Cells were grown to mid log phase ODg^ o = 0.5. 15 mis of cells were harvested at 600 g, 
washed once in 0.1 M TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 7.5) and once in 0.1 
M Lithium acetate/ 0.1 M TE. Cells were then resuspended in 100 /d 0.1 M Lithium 
acetate/ TE. 15 /d of 10 mg/ml herring sperm DNA boiled for 15 minutes was added along 
with 0.1-1 pg of transforming DNA. The mix was then vortexed briefly, 700 40 %
PEG4000 in 0.1 M lithium acetate/ TE added and vortexed again. The transformation was 
incubated at room temperature for 90 minutes on a rotator then heat shocked at 42“C for 15 
minutes. Cells were spun down in a microfuge and resuspended in 100 fi\ of sterile water 
and plated on selective plates.
47
2.4.7 ‘Knock in’ Strategy of Generating Integrated Gene Deletion or 
Tagged Strains.
A set of plasmids exist that allow genes within the yeast genome to be easily tagged or 
deleted (Longtine et al, 1998). These plasmids allow amplification of a tag or stop codon 
and selection marker by PCR (see section 2.2.5) using oligonucleotides that have been 
designed with regions of homology to a specific site in the yeast genome. Transformation 
of this PCR product into yeast cells (see section 2.3.5) allow its incorporation into the 
specific site in the yeast genome via homologous recombination. The transformation 
mixture is spread onto plates lacking certain nutrients, allowing selection of transformed 
cells.
2.4.8 Screening for Integrated Tags or Gene Deletions by Colony PCR.
After transformants have grown into colonies they were struck out onto YPAD plates and 
incubated at 30°C overnight. The next day, a single colony was picked using a toothpick 
and resuspended in 20 fxl of SPZ Buffer (1.2 M sorbitol, 0.1 M Potassium Phosphate buffer 
pH7.5 and 2.5 mg/ml zymolyase (ICN Biomedicals)). Cell suspensions were incubated at 
37°C for 30 minutes and boiled for 5 minutes. This crude prep was used as the template in 
a standard PCR (see section 2.2.5) that used oligonucleotides that were designed to the 
regions flanking the insert region. This PCR would either generate a wild type band or a 
larger integration band. PCR products were visualised by running on an agarose gel (see 
section 2.2.6).
2.4.9 Temperature Sensitivity.
A single colony of cells was picked using a toothpick and was resupended in 100 fû of 
water in a well of a frogging pond. Cells were frogged out onto YPAD plates and
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incubated at either 30°C or 37°C for 1-2 days to assess if a strain has a temperature 
sensitive defect.
2.4.10 Measuring Cell Number and Generation Times.
An overnight culture was used to inoculate 100 ml of cells to a cell density of about 5x10^ 
cells/ml. Cells were grown for 1.5 hours at 26°C in a shaking incubator. The culture was 
split into 2 X 50 ml cultures and then incubated at 26°C and 37°C for 30 minutes. A 500 fil 
sample was removed and sonicated for 10 seconds. The sample was diluted 1:200 with 
Casyton^M buffer and then the cell number was measured in the Scharfe system CAS Y 1™. 
This was repeated at various time points.
2.4.11 Screen to Identify Genes That When Overexpressed Can Rescue 
the ABPl Dependent Phenotype of slalACt Mutant Cells.
KAY599 cells were transformed with pKAl 1 {URA marked) (see section 2,3.5) and were 
then crossed with cells expressing slalACt (KAY369) to generate a strain lacking ABP7 
and expressing the slalACt mutation that were viable due to expression of functional ABPl 
from pKAl 1. This strain was then transformed with 20 /xg of a YEpl3 {LEU marked) 
expression library using the yeast 2-hybrid library transformation protocol (see section 
2.4.3). Cells were spread onto plates containing media lacking uracil and leucine and 
incubated for about 3 days at 30°C. Transformed cells were then replica plated onto plates 
media lacking leucine and containing 0.1% 5-FOA (5-Flurooorotic acid, Melford 
laboratories) to select against the URA marked plasmid expressing functional ABPl 
(pKAll). This reagent is toxic to yeast cells expressing the URA genes. For cells to grow 
in the presence of 5-FOA they must therefore lose the URA marked plasmid, so only inserts 
capable of rescuing the lethal phenotype of these cells will produce a viable colony. These 
plates were incubated at 30“C for one week.
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After a week incubation of these plates colonies were clearly visible. 150 colonies of 
varying sizes were picked. The library plasmid was then rescued from these cells (see 
section 2.4.5) and PCR was used to screen for plasmids containing ABPl or SLAI inserts. 
Of the 150 colonies only 9 were sequenced.
2.4.12 lodination of the MFN5 peptide.
The MFN5 peptide (Siegal et al, 1999) was iodinated with chloramine T as desribed in 
(Olah et al, 1994). Briefly, the MFN5 peptide was resuspended in 0.3M sodium dihydrogn 
phosphate, pH7.5, to a concentration of 0.5 mg/ml. To this 1.5 mCi of was added, 
followed by 100 jal of a 1 mg/ml chloramine T solution. After 4 minutes at room 
temperature , the reaction was stopped by addition of 150 /xl of a 0.5 mg/ml sodium 
metabisulfate solution. The entire solution was passed through a ? column to remove 
unbound iodine. Fractions were collected in centrifuge tubes and their specific 
radioactivity was determined using a COBRA™ Auto-Gamma counter (Packard).
2.4.13 a-factor uptake assays.
YPAD plates were spread with 200 /xl (2x10^ cells) from an overnight culture of either 
KAY316 or KAY391 cells. Plates were incubated overnight at 30°C. Cells were 
resuspended in 10 ml YPAD + IM sorbitol and centrifuged at 500 g for 5 minutes to 
remove budded cells. The supernatant was decanted into a fresh tube and cells were 
harvested by centrifugation. Cells were resuspended in 2 ml ice cold YPAD to a 
concentration of 5x10® cells/ml.
a-factor internalisation assays were performed essentially as described previously (Dulic et 
al, 1991). Approximate 8x10^ counts/minute ‘^ 3-MFN5 was added to the 2 ml cell 
suspension on ice. ^^^I-MFN5 peptide was allowed to bind to cells on ice for one hour.
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Unbound MFN5 peptide was removed by centrifugation and cells were allowed to initiate 
peptide internalisation by adding 2 ml prewarmed YPAD and incubating at 30°C. At 
various time points, tubes were vortexed briefly and 100 jal cell aliquots were removed and 
washed in 1ml p H l.l or pH6, O.IM potassium phosphate buffer. The amount of cell 
associated radioactivity after each wash was determined by gamma counting in a 
COBRA™ Auto-Gamma counter (Packard). The amount of a-factor peptide internalised is 
expressed as a ratio of pH 1.1-resistant to pH6-resistant radioactivity. To determine the fold 
increase in uptake, the pHl.l/pH6 ratio was divided by the starting value in each case.
2.5 Yeast 2-Hybrid Protocol.
2.5.1 Construction of Bait Plasmid pGBDU-HDl+HD2.
The bait plasmid to be used in the yeast 2-hybrid screen was constructed by subcloning the 
central region, containing HDl and HD2, of SLAI into the pGBDU-C3 vector. To achieve 
this, the central region (nucleotides 1461-2192) of SLAI was amplified by PCR, using 
Biolone Taq, from pKAl. The primers used were designed so that Pstl (oKA184) and 
BamHl (oKA185) restriction sites flank the region of interest. The amplified region central 
region was then subcloned into the Pstl/BamHl restriction sites of pGBDU-C3. This 
created an in-frame fusion of the central region of SLAI to the GAL4 DNA binding domain 
on the bait vector (pDWl). pDWl was sequenced from the 5’ and 3’ ends using 
oligonucleotides oKA182 and oKA183 respectively which bind pGBDU-C3 regions 
flanking the insert.
2.5.2 Testing pDWl for Self-Activation.
In order to check that the pDW 1 plasmid did not self-activate transcription of the reporter 
genes, 2 fig of the plasmid was co-transformed into KAY438 with 2 pg of empty activation
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plasmid (pGAD-Cl). The cells were first grown on plates selecting for both plasmids and 
then transferred onto plates selecting for the expression of reporter genes.
For a negative control yeast cells were co-transformed with empty pGBDUC-3 (binding 
domain plasmid) and empty pGAD-Cl (empty activation domain plasmid). These cells 
were struck onto plates selecting for both plasmid and then transferred to plates selecting 
for expression of the reporter genes as before.
2.5.3 2-Hybrid Library Transformation.
pDWl was transformed into KAY438 as described in section 2.2.5 . This strain (KAY581) 
was then grown overnight in liquid media lacking uracil at 30°C. This culture was diluted 
into 100 mis and incubated in a 30°C shaking incubator until the cell density was 
approximately 2x 10^  cells/ml. Cells were harvested by centrifugation at 600 g for 4 
minutes. The cell pellet was washed in sterile water and then centrifuged as before. The 
following was added to the cell pellet: 360 /xl 1 M lithium actetate; 2.4 ml 50 % PEG4000; 
50 /xl (boiled 15 minutes and then put on ice) herring sperm DNA (15 mg/ml); 20 /xg 
library DNA from pGADC-1/2/3 and 680 /xl sterile distilled water. The mixture was then 
vortexed for one minute, incubated at 30°C for 30 minutes and then heat shocked at 42°C 
for 30 minutes with gentle mixing every 5 minutes. Cells were harvested by centrifugation 
at 600 g for 4 minutes and the resulting cell pellet was resuspended in 3.6 ml sterile 
distilled water. The cell suspension was spread onto 8 x 140mm diameter selective media 
(lacking uracil and leucine) plates to select for the bait (URA) and the prey (LEU) 
plasmids. Cells were allowed to grow for two days at 30°C.
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After two days growth at 30°C the transformation had grown to confluence. Cells were 
replica plated onto plates to select for expression of the reporter genes,the media lacked 
uracil, leucine, histadine and adenine (amino acid drop-out mix from BIO 101), using 
Whatman paper to transfer cells onto the 8 x 140 mm plates.
2.5.4 Elimination of False Positives.
To remove as many false positives from the library screen before the plasmids were rescued 
or sequenced, strains were struck onto plates that lacked adenine but contained 0.1% 5- 
FOA (5-Fluoroorotic acid, Melford laboratories). This reagent is toxic to cells expressing 
the URA genes. For cells to grow in the presence of 5-FOA they must therefore lose the 
bait (URA marked) plasmid. Any cells that are able to grow on this media are false 
positives because the media is selecting for cells expressing one of the reporter genes 
(adenine), these cells are activating their reporter genes but only contain the prey plasmid.
2.5.5 Extraction of Yeast 2-Hybrid Library Plasmids.
Yeast cells were grown overnight in liquid media lacking uracil and leucine. Cells were 
harvested from 1 ml of overnight culture by centrifugation at 5000 rpm for one minute in a 
bench top microfuge. The cell pellet was resuspended in 500 /xl Buffer S (10 mM 
potassium phosphate buffer pH 7.2; 10 mM EDTA; 50 mM p-mercaptoethanol and 50 
/xg/ml zymolyase) and incubated at 37“C for 30 minutes. Next 100 /xl of Lysis Buffer (25 
mM Tris-HCl pH 7.5; 25 mM EDTA; 2.5 % (w/v) SDS) was added to the cells and the cells 
were mixed by vortexing. Cells were incubated for a further 30 minutes at 65°C before the 
addition of 166 /xl 3M potassium acetate (pH 5.5). Cell suspensions were then incubated on
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ice for 10 minutes before centrifugation at top speed for 10 minutes in a bench top 
microfuge at 4°C. The supernants were transferred to fresh tubes on ice containing 800 /xl 
of 100 % ethanol and left for 10 minutes. DNA was pelleted by centrifugation at top speed 
for 10 minutes in a bench top micrafuge at 4°C, washed in 70 % ethanol and allowed to air 
dry. The pellet was then resuspended in 40 /xl sterile distilled water. These plasmid 
preparations contain both the URA3 and the LEU2 marked 2-hybrid plasmids. To select for 
the LEU2 marked (library) plasmids, these preparations were transformed into 
electrocompetent KC8 cells, which lack a functional LEUB gene. This E.coli strain 
contains a leuB mutation, which allows for the direct selection of the yeast LEU2 gene 
carried on the library plasmids.
2.5.6 Preparation of Electro-Competent KC8 Cells.
A 2 ml overnight culture of KC8 cells was used to inoculate 400 ml of 2 x YT media. Cells 
were incubated in a 37°C shaking incubator and grown to an approximate ODg^o  ^0.5-0.6. 
Cells were cooled on ice for 30 minutes and the harvested by centrifugation at 3000 g for 
10 minutes at 4°C. The cells pellet was resuspended in 50 ml ice-cold sterile water, mixed 
and the centrifuged as before. This washing step was repeated again. The cell pellet was 
then resuspended in 20 ml of ice cold 10 % glycerol, cells were harvested by centrifugation. 
The cell pellet was resuspended in an equal volume of ice cold 10 % glycerol. Cells were 
then aliquoted (50 /xl/transformation) into microcentrifuge tubes and frozen on dry ice.
Cells were stored at -80°C until needed.
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2.5.7 Electroporation of KC8 Cells with Yeast 2-Hybrid Plasmid 
Preparations.
Cells were electroporated with the 2-hybrid plasmid preparations, incubated at 37°C for 30 
minutes in 2 x YT, before plating onto M9 plates lacking leucine that allow for the 
selection of LEU2 marked library plasmids. Plates were incubated overnight at 37°C.
Colonies were picked and grown in a small volume (2 ml) of 2 x YT +100 /xg/ml 
ampicillin. Plasmids were extracted from the KC8 cells using the Qiagen miniprep kit (see 
section 2.1.9) and transformed into chemically competent DH5a cells (see section 2.1.8 ). 
This subsequent transformation allowed stocks of the plasmids recovered to be stored as 
DH5a cells are better at maintaining plasmids.
2.5.8 Checking the Rescued Plasmids Activate Expression of the 
Reporter Genes.
To check that the activation plasmids had been rescued from the yeast cells and the 
activation was real, the rescued library plasmids were retransformed into KAY582. Each 
plasmid was checked that it was able to activate expression of the reporter genes in 
combination with the bait plasmid pDWl, by growing on media lacking adenine and 
histidine.
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2.6 Protein Methods.
2.6.1 Whole cell yeast extracts.
Cells were grown in liquid media overnight in a shaking incubator at 30°C. Cells were 
harvested from 1.5 mis of the overnight culture by centrifugation in a bench top microfuge 
at 3000 g for one minute. 100 /tls of acid washed glass beads were added to the pellet 
along with 25 {ils of 2 x SDS sample buffer (62.5 mM Tris-HCl (pH 6.8), 20 % glycerol, 2 
% SDS, 0.0025 % bromophenol blue). Cells were then boiled for three minutes and 
vortexed for one minute. Another 100 fiis of 2 x SDS sample buffer was added and the 
protein sample was vortexed briefly. Before the protein is separated on a SDS gel the 
sample was boiled for an additional one minute.
2.6.2 Protein preps by grinding in liquid nitrogen.
An overnight culture of cells was diluted into 100 mis of the appropriate growth media and 
grown to an ODQQo=1.0. Cells were harvested by centrifuging at 3000 g for 5 minutes. The 
cell pellet was resuspended in 1 ml of the appropriate buffer and frozen in liquid nitrogen 
for 10 minutes. Cells were the ground in the presence of liquid nitrogen, using a pestai and 
mortar. The cell extract was collected into 1.5 ml eppendorf tubes and stored at -80°(u until 
required.
2.6.3 Immunoprécipitation procedures.
Yeast cells were lysed by liquid nitrogen-grinding method in IP buffer (0.5 mM KCl, 2 mM 
EDTA, 25 mM HEPES (pH 7.5), 0.5 % Triton X-100) freshly supplemented with 1 mM 
PMSF and aqueous phase protease inhibitors. The cells lysate was centrifuged at 100,000 g 
for 20 minutes at 4“C in a TLA 100 rotor (Beckman™). 500 /tl of the high-speed
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supernatant was pre-cleared by adding 2 }x\ 50 mM Latrunculin-A and 10 /d mouse IgG- 
agarose conjugate (Santa Cruz, USA). Samples were incubated at 4°C for one hour with 
mixing. The agarose-conjugated antibody was removed by centrifugation at 3000 rpm for 4 
minutes at 4°C. The pre-cleared supernatant was transferred to a fresh tube and 20 /xl of 
mouse anti-HA agarose conjugated antibody (Santa Cruz, USA) was added. Samples were 
incubated at 4°C for one hour with mixing. Antibody bound proteins were harvested by 
centrifugation at 3000 g for 4 minutes at 4°C. Beads were washed three times in IP buffer.
2.6.4 Treatment of immunoprecipitated proteins with A.-phosphatase.
After washing, beads were resuspended in IP buffer and treated with X-phosphatase (New 
England Biolabs) for 30 minutes at 37°C. Proteins were eluted from the beads by addition 
of 40 /xl 2 X SDS sample buffer and then boiling for one minute.
2.6.5 Fractionation of yeast cell extracts.
Cell extracts for sucrose gradient fractionation were prepared by the liquid nitrogen- 
grinding method in UBT (50 mM KHEPES, pH 7.5, 100 mM KCl, 3 mM MgCl^, 1 mM 
EGTA, 0.5 % Triton X-100) freshly supplemented with 1 mM PMSF and aqueous phase 
protease inhibitors. The lysate was thawed at 4°C and spun at 3000 g for 4 minutes at 4°C 
to clear unlysed cells. The supernatant was then spun at 100,000 g for 20 minutes at 4°C to 
obtain a high-speed supernatant to load onto the sucrose gradient.
2.6.6 Sucrose gradients
Linear sucrose gradients (11 ml of 3-30%) were prepared in Ultra-Clear tubes (Beckman, 
USA). Samples (500 /xl) of yeast extract were layered on top. The gradients were spun at 
35,000 rpm in an SW41 rotor for 18 hours at 4°C. Fractions (400 /xl) were removed from
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the bottom of the gradient and assayed on SDS-PAGE. Immunoblotting was used to 
determine the position of various proteins.
2.6.7 SDS-PAGE electrophoresis.
The appropriate percentage of acrylamide gel was poured according to the recipes below. 
Separating gel:
Sterile water
30 % acrylamide, 0.8 % bisacrylamide (37.5:1) 
Bottom Buffer (1.5 M Tris-HCl (pH 8.8),
0.4 % SDS)
10 % ammonium persulfate 
TEMED
5 % Stacking gel;
Sterile water 1.71 mis
30 % acrylamide, 0.8 % bisacrylamide 0.50 mis
Top buffer (0.5 M Tris-HCl (pH 6.8), 0.4 % SDS) 0.75 mis
10 % ammonium persulfate 35 /xls
TEMED 3.5 /xls
Gels were run in 1 x Running buffer (0.025 M Tris, 0.192 M Glycine, 0.1 % SDS, pH 8.6) 
at 120 volts for approximately 1.5 hours, until the dye front has run off the bottom of the 
gel.
7.5 % 10% 12%
4.10 mis 3.44 mis 2.69 mis
2.25 mis 3.00 mis 3.75 mis
2.25 mis 2.25 mis 2.25 mis
31 /xls 31 Ills 31 fils
5 fx\s 5 fils 5 fils
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2.6.8 Western blotting.
Proteins were separated by SDS-PAGE electrophoresis as described above. The PVDF 
membrane and 3 mm filter paper were eut to size. The PVDF was soaked in methanol 
while the filter paper and two Scotchbrite pads were soaked in ice-cold blotting buffer (10 
mM CAPS, 10 % methanol, pH 11). The blot sandwich was assembled keeping everything 
wet and care was taken to exclude air bubbles. The sandwich was then placed in the 
blotting apparatus, with the membrane toward the anode. An ice pack was placed in the 
apparatus to keep the transfer cool and blotting was performed at 400 mAmps for one hour.
2.6.9 Western blot detection nsing Enhanced Chemi-Lnminescence 
(ECL).
Proteins are blotted as described above. The wet membrane was blocked at room 
temperature for about 30 minutes in 5 % milk powder in 1 % TEST (1 x TBS + 0.2 % 
Tween-20), The membrane was then rinse briefly in 1 x TEST and was then placed in a 
plastic bag with 3 mis of blocking solution plus primary antibody (concentrations as 
described in the text). The membrane was incubated in the presence of primary antibody 
for either one hour at room temperature with shaking or overnight at 4“C with shaking. The 
blot was then removed from the plastic bag and washed with 1 x TEST briefly followed by 
one 15 minute and two 5 minute washes in 1 x TEST. The membrane was placed in a 
plastic bag and incubated with blocking solution containing horseradish peroxidase 
conjugated secondary antibody (usually 5000 x dilution) for between 30 minutes and one 
hour at room temperature with shaking. The membrane was removed from the plastic bag 
and washed as before but with an additional 5 minute wash in 1 x TEST. In the dark room 
equal volumes of developing reagents (Solution 1 : 250 mM luminol (3- 
aminophthalhydrazide from Fluka No 09253) in DMSG, 90 mM p-coumaric acid in 
DMSO, 0.1 M Tris-HCL pH 8.5; Solution II: hydrogen peroxide, 0.1 M Tris-HCl pH 8.5)
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were mixed and the membrane was incubated in the developing solution for at least one 
minute. The solutions were then drained off and the membrane wrapped in cling-film. The 
membrane was then exposed to X-ray film (Konica) in a cassette and the film was 
developed in an automatic developer.
2.6.10 Western blot detection using Alkaline Phosphatase.
The blotted membrane is probed with antibodies as above except the secondary antibody is 
an alkaline phosphatase conjugated antibody (cocentrations as described in the text). After 
incubation with secondary antibody, the membrane was washed as above. The membrane 
was then developed in 10 mis of developing solution (100 mM NaCl, 5 mM MgClg, 100 
mM Tris (pH 9.5)) containing 132 /xls of NBT (nitro blue tétrazolium) stock (0.5 g in 10 ml 
50 % DMF) and 66 fils BCIP (5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt) stock 
(0.25 g in 10 ml 100 % DMF). After sufficient colour development the reagents were 
washed off with water and the membrane was air-dried.
2.6.11 2-Dimensional gel electrophoresis.
Whole cell extracts were prepared in Rehydration Buffer (9 M Urea, 2% CHAPS, 0.2%/ 
1:200 Ampholine (pH 3-10), 2.8 mg DTT). Whole cells extracts were centrifuged at 3000 
g for 5 minutes at 4°C in a bench top microfuge. A few grains of bromophenol blue were 
added to the supernatant and 500 /xl of extract was placed into a well of the rehydration 
tray. A Dry strip (pH 3-10, 18 cm, Amersham Pharmacia) was carefully placed face down 
into the whole cell extract, excluding any air bubbles. The Dry strip was then covered in 3 
ml of Drystrip Cover Fluid (Amersham Pharmacia) and the gel strips were allowed to 
rehydrate overnight at 4°C. Hydrated drystrips were placed on the flat bed of a Multiphor 
II system (Amersham Pharmacia) and the first dimension was run under the following 
conditions: STEPl 500 V, 2 mA, 5 W, for 1 minute; STEP2 3500 V, 2 mA, 5 W, for 1.5
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hours; STEPS 3500 V, 2 mA, 5 W, for 6.5 hours. Before running the second phase, the 
Drystrip was equilibrated by soaking in SDS sample buffer for 30 minutes. The Drystrip 
was then placed on top of a 3-15% SDS separating gradient gel, encased in 1% agarose and 
run through the gel at 10 mAmps with cooling overnight. Western blotting was then 
performed, HA-tagged proteins were detected by probing with Rabbit aHA (1:1000) and 
aRabbit HRP (1:5000).
2.7 Microscopy methods.
2.7.1 Live cell microscopy methods.
2.7.1.1 Lucifer Yellow staining of vacuoles.
Cells were grown to an ODgoo = 0.25. 0.5 ml cells harvested in a bench top microfuge and 
resuspended in 30 /xl YPAD liquid. 10 /xl of 40 mg/ml Lucifer yellow was added and 
incubated at room temperature for one hour in the dark. Cells were washed three times in 
ice cold succinate/azide buffer and resuspended in 10 /xl of buffer and kept on ice until 
viewed with an Olympus microscope BX-60 fluorescence microscope containing an lOOW 
mercury lamp and an Olympus 100 X Plan-NeoFluar oil immersion objective. Images were 
captured using a Roper Scientific Micromax 140E cooled CCD camera using IP lab 
software (Scanalytics, Fairfax, VA) on an Apple Macintosh G4 computer.
2.7.1.2 Visualisation of GFP tagged proteins.
A 10 /xl aliquot of a mid-log phase 0.2-0.4 was removed and placed on a glass slide.
A coverslip was place over the liquid and GFP tagged proteins were visualised on the 
fluorescence microscope.
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2.7.2 Fixed cell microscopy methods.
2.7.2.1 Indirect Immunofluorescence
Mid-log cultures were fixed in 5 % final volume formaldehyde solution for between 30-60 
minutes. Cells were then harvested in a bench top microfuge and washed twice in KPi + 
sobitol (1.2 M sorbitol, 0.1 M Potassium phosphate buffer, pH 7.5). Cells were 
resuspended in KPi sorbitol buffer. 1 /xl of p-mercaptoethanol and 20 /xl 1 mg/ml lOOT 
zymolyase was added. Tubes were incubated at 37“C for 35 minutes. 20 /xl of the cell 
suspension was placed onto a well of a slide that had been lined with poly-l-lysine. Cells 
were allowed to settle for 10 minutes, then aspirated off gently. The well was covered with 
0.1 % SDS solution for a maximum of 1 minute and then washed 10 times with PBS 4- 0.1 
% BSA. Next 20 /xl of PBS/BSA 4- primary antibody was placed on the well. The slide 
was incubated for 1 hour in the dark. The well was washed 10 times with PBS/BSA, then 
incubated for 1 hour covered in PBS/BSA 4- secondary antibody. The well was washed 
again 10 times with PBS/BSA then a drop of phenylenediamine mounting solution (1 
mg/ml p-phenylenediamine, 22.5 ng/ml 4’6’ Diamidino 2-phenylindole dihydrochloride 
(DAPI) in Glycerol) was placed onto each well. A cover slip was placed over the wells and 
sealed with nail polish around the edges.
2.7.2.2 Rhodamine phalloidin staining.
Cells were grown to an OD6oo=0.2-0.4, fixed in 5 % final volume of formaldehyde solution 
for one hour at room temperature and then harvested in a microfuge. The cell pellet was 
washed three times in 0.1 M PBS/0.1 M BSA/0.1 % triton and then resuspended in 40 /xl of 
0.1 M PBS/0.1 M BSA/1 % triton plus 5 /xl Rhodamine phalloidin. Cells were incubated at 
room temperature for 30 minutes in the dark, washed three times with 0.1 M PBS/0.1 M 
BSA and resuspended in 100 /xl of the above. Cells were placed in poly-l-lysine coated
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wells allowed to settle for 10 minutes, washed twice with 0.1 M PBS/0.1 M BSA and then 
mounted with a drop of mounting solution before the cover slip was sealed with nail polish. 
Slides were then viewed on the fluorescence microscope.
2,1,23 Electron Microscopy.
Cells were grown to early log phase (OD6oq=0.4 -  0.6) and harvested at 3000 g for 5 
minutes. The cell pellet was rinsed in 1.5 ml of fixative (0.04 M potassium phosphate 
buffer (pH 6.7), 1 M sorbitol, 3 % formaldehyde, 0.5 % glutaraldehyde (EM grade, 
Polysciences), 1 mM Mgcl2, 1 mM CaClj, final pH should be between 6.5 and 7).
Resuspend pellet in Fixative and incubate at room temperature for two minutes. Cells were 
washed three times with 50 mM potassium phosphate buffer (pH 7.4) and then incubated in 
4 % potassium permanganate for four hours. After this, cells were washed four times with 
sterile water. 2 % filter sterilised uranyl actetate was added and cells were incubated 
overnight at 4°C, with mixing. In the next step cells were dehydrated, by washing them in 
increasing concentrations of ethanol. Cells were washed twice with 50 % ethanol over 10 
minutes and then twice in 70 % ethanol over 10 minutes. Next cells were washed in 80 %, 
90 %, 95 % ethanol for 5 minutes each and then three times in 100 % ethanol over 30 
minutes. 50 % White Resin (Agar scientific, Cambridge, UK) in ethanol was added and 
cells were incubated at room temperature for two hours with mixing. Cells were harvested 
by centrifugation and then resuspended in 100 % White Resin and incubated at room 
temperature overnight with mixing. Cells were harvested by centrifugation and the tube 
was filled to the top with 100 % White Resin. Tubes were incubated at 60°C overnight. 
Samples are now ready to be sliced and stained. Sections were prepared on an 
ultramicrotome. Sections were silver in interference colour, corresponding to a thickness of 
between 50 -  70 nm. The thinnest sections provide the best resolution.
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Chapter 3.
Characteriastion of the slalACt Mutant and the Role of
Slalp in Endocytosis.
3.1 Background.
Slalp has been demonstrated to be required for the proper organisation of the yeast cortical 
actin cytoskeleton (Holtzman et al, 1993; Ayscough et al, 1999). A previous study using 
plasmid borne domain deletion mutants of SLAÎ indicated that the C-terminal repeat region 
of Slalp was required to rescue the Abp 1 p-dependent phenotype but not the actin 
phenotype associated with the Aslal deletion (Ayscough et al, 1999). However, the 
slalACt mutant used in this study did not lack the entire C-terminal repeat region, only 
approximately two thirds of this region was deleted.
To elucidate further the functions of the C-terminal repeat region of Slalp, an integrated 
slalACt mutant was constructed that lacked the entire C-terminal repeat region. This 
chapter concentrates upon the phenotypes that are associated with this mutant.
3.2 Results.
3.2.1 Construction of an integrated slalACt mutant.
The ‘knock-in’ strategy (figure 3.1) was used to construct a strain lacking the region 
encoding for the entire C-terminal repeat region of SLAl from the genome (see Materials 
and Methods section 2.4.7 and Longtine et al, 1998). Briefly, primers designed to the
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region of interest are used in amplify a tag and stop codon from a set of plasmids (Longtine 
et al, 1998). The PCR product is transformed into yeast and insertion of the PCR product 
into the genome occurs via homologous recombination. Colonies are picked and screened 
to check that the PCR product has integrated into the correct site in the genome by colony 
PCR (see Materials and Methods section 2.4.8). Western blotting is then performed to 
check for expression of tagged proteins. As shown in figure 3.1, the slalACt-myc mutant is 
expressed in the yeast cells.
3.2.2 Temperature sensitivity and Growth.
Previous studies have shown that SLAl null cells are temperature sensitive (Holtzman et al, 
1993). To test whether cells expressing slalACt are also temperature sensitive, cells were 
incubated at 30 and 37°C on YPAD plates. As reported previously, cells lacking SLAl 
were inviable at 37°C. Cells expressing slalACt were viable at 37°C (Figure 3.2a), 
showing that cells lacking the C-terminal repeat region of Slalp are not inviable at high 
temperatures. However, cells expressing slalACt appeared to grow at a slower rate at 37°C 
on plates compared to wild type cells.
To study the rates of growth in liquid media, growth curves were performed. Cells were 
grown in YPAD liquid media at 30 and 37°C and samples were removed at two hour time 
points to determine the cell number in each culture (Figure 3.2b). At 30°C cells expressing 
slalACt grew at about the same rate as wild-type cells, both having a doubling time of 
about 2 hours. At 37“C wild type cells had a doubling time of about 2 hours, compared to 
cells lacking the C-terminal repeat region of Slalp with a doubling time of about 4.5 hours. 
Although these cells are able to grow at high temperatures, they do have a slow growth 
defect at 37°C.
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3.2.3 Cells expressing slalACt have a relatively normal cortical actin 
organisation.
The actin organisation of yeast cells can be examined by fluorescence microscopy using 
rhodamine phalloidin, a specific stain for filamentous actin (See Methods and Materials 
section 2 1 2 2  and Pringle et al, 1989). Wild type cells contain small, punctate cortical 
actin patches that become highly polarised to the growing bud (Figure 3.3a). As reported 
previously cells lacking SLAl (Figure 3.3b) contain fewer, larger chunks of actin that are 
poorly polarised (Holtzman et al, 1993). Cells expressing slalACt contain a relatively 
normal cortical actin cytoskeleton (Figure 3.3c). Most cells contain small, punctate patches 
that become highly polarised. However in about a quarter of these cells a larger chunk of 
actin is also observed in cells containing small punctate patches.
3.2.4 Effect of Latrunculin-A treatment on the actin cytoskeleton.
Previous studies have shown that Latrunculin-A (LAT-A) is an actin cytoskeleton- 
disrupting drug that binds to actin monomers preventing the assembly step in a rapid cycle 
of assembly and disassembly (Ayscough et al, 1997, Morton et al, 2000). Cells lacking 
SLAl have been shown to have a reduced sensitivity to Latrunculin-A in halo assays 
compared to wild-type cells, suggesting a reduction in actin dynamics caused by the 
deletion (Ayscough et al, 1997). Halo assays were performed to examine the effect of the 
slalACt mutation on cells sensitivity to LAT-A. Cells expressing slalACt demonstrated a 
smaller halo size then wild-type cells (Figure 3.4a), indicating that these cells are less 
sensitive to the effects of LAT-A. Figure 3.4b shows the apparent relative sensitivity of 
each strain to the effects of LAT-A (see materials and methods section and Reneke et al, 
1988).
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(A ). W ild type (B). Aslal (C ). slalACt
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Figure 3.4. Effect of the slalAC t mutation on the sensitivity of cells to Latrunculin-A 
treatment. Halo assays were performed to assess the sensitivity of cells expressing 
slalACt to LAT-A. Concentrations measured 1 mM, 2 mM and 5 mM. (A) Wild type 
(KAY302), (B) Aslal (KAY300) and (C) slalAC t (KAY369) cells. (D) Comparison of the 
apparent relative sensitivity of wild type (KAY302) and slalAC t (KAY369) cells to the 
effects of LAT-A (See Materials and Methods section and Reneke et al, 1988).
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3.2.5 Cells expressing slalACt require expression of functional ABPl for 
viability.
Slalp was originally identified in a synthetic lethal screen with ABPl (Holtzman et al, 
1993). Studies with plasmid borne Slalp lacking approximately two thirds of the C- 
terminal repeat region demonstrated that this region was required to rescue the Abp Ip 
dependence of cells (Ayscough et al, 1999). To test whether cells expressing the integrated 
slalACt mutant, lacking the entire C-terminal repeat region, are Abp Ip dependent a strain 
lacking ABPl was crossed with the slalACt mutant. The resulting diploid cells were 
sporulated and the tetrads dissected. The possible outcomes from this cross are shown in 
Figure 3.5a.
If cells expressing slalACt are not Abp Ip dependent then all progeny from this cross will 
be viable as is the case when cells lacking ABPl are crossed with wild type cells (Figure 
3.5.b). As shown in figure 3.5.b most tetrads contained at least one of spore that failed to 
grow into a colony on YPAD plates suggesting that cells expressing slalACt are Abp Ip 
dependent. To clarify which combinations of mutations are viable cells were plated onto 
the appropriate selective media to select for the specific mutations. Figure 3.5.c shows a 
representative tetrad from which only three spores grew into colonies. None of the viable 
colonies from the AabplfslalACt cross were able to grow on both selection plates 
suggesting that cells expressing slalACt depend on the expression of a functional ABFi 
gene for viability.
3.2.6 Cells expressing slalACt contain aberrant cell wall morpbology.
Cells lacking SLAl have been shown to contain aberrant cell wall morphology. These cells 
contain a thick cell wall around the mother cells probably due to the aberrant localisation of 
Rholp, the regulatory subunit of (3-glucan synthase in these cells (Ayscough et al, 1999).
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(A ). ABPl::leu2
X
ahplA::LEU2
ABPl
ahplA::LEU2
ABPl
abplA::LEU2
slaJACt::TRPl
SLAl::trpl
Outcomes
slalACt::TRPl
SLAI
SLA I
slalACt::TRP
Known phenotypes
leu2 TRPl VIABLE
LEU2 trpi VIABLE
leu2 trpl VIABLE 
LEU2 TRPI ?
(B). SLAI s la lA C t  
T 1 T 2  T 3  T1
S p o r e  A
(C).
sla lA C tA ahpl
slalAC t ABPl
SLAI abplA
SLAI ABPl
YPAD do trp do leu
Figure 3.5. Abp Ip dependence of cells expressing slalACt. (A) Possible outcomes of a 
cross between cells lacking ABPl (KAY 126) and cells expressing slalAC t (KAY369). 
Haploid cells were crossed and the resulting diploid cells were sporulated. (B) Tetrads were 
then dissected and spores allowed too grow on YPAD plates at 30°C to observe how many 
were viable from each tetrad. All viable colonies were patched onto the appropriate selective 
media to determine which combination of mutations were viable. (C) representative tetrad 
patched onto appropriate selection plates.
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(A). SLAI (B). sla lACt (C). Aslal
Figure 3.6. Aslal null cells and cells expressing slalACt have thick cell walls. (A) Wild 
type (KAY302), (B) AslalACt (KAY369) and (C) Aslal (KAY300) cells were grown to log 
phase and then fixed and processed for electron microscopy using potassium permanganate 
fixation to enhance visualisation of the cell wall and membranes.
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In order to ascertain if cells expressing slalACt contain thick cell walls, electron 
microscopy was used to observe the yeast cell wall (see Methods and Materials section 
2.1.23). As reported previously cells lacking SLAI contained a thick cell wall around the 
mother cell. A thick cell wall was also observed around the mother cell of cells expressing 
slalACt (Figure 3.6).
3.2.7 The C-terminal repeat region of Slalp is required to localise the 
protein to the cell cortex.
Slalp has been shown to localise to the cell cortex in a patch structure that partially 
overlaps with cortical actin patches, about 50% of the Slalp patches colocalised with actin 
patches (Warren et al, in press). To study the importance of the C-terminal repeat region in 
targeting Slalp to the cell cortex, a myc tagged form of slalACt was generated.
The localisation of slalACtp-myc was observed by indirect fluorescence microscopy (see 
Methods and Materials section 2.7.2.1; Ayscough and Drubin, 1998). Slalp-myc localised 
to the sites of cell growth in small patch structures as was reported in earlier studies (Figure 
3.7a). Slal ACtp-myc did not show any punctate cortical staining indicating that the C- 
terminal repeat region of Slalp is required for its localisation to the cell cortex (Figure 
3.7b).
3.2.8 Slalp localisation to the cell cortex is mediated by an interaction 
with End3p.
The Slalp C-terminal repeat region has recently been shown to interact in 
immunoprécipitations with the Fanlp/End3p complex (Tang et al, 2000). As Slalp lacking 
this region does not localise to the cell cortex it would suggest that the interaction between
74
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the C-terminal repeat region and this complex are required to localise Slalp to the cell 
cortex. To investigate the importance of EndSp for the localisation of Slalp, a strain 
containing the end3-l temperature sensitive allele (Benedetti et al, 1994) and GFP tagged 
SLAI was constructed.
At the permissive temperature both wild type and end3-l cells had a normal cortical actin 
organisation and Slalp-GFP was organised into small punctate patches that became 
polarised through the cell cycle. After wild type cells were incubated at the 37°C for two 
hours the cortical actin organisation and the Slalp-GFP localisation remained the same as 
at 29°C. However, after two hours incubation at the non-permissive temperature, end3~l 
cells contained an aberrant cortical actin organisation (Figure 3.8). In these cells there were 
fewer cortical chunks of actin that were poorly polarised. These cells had also lost Slalp- 
GFP from the cell cortex and instead contained a diffuse cytoplasmic staining 
demonstrating that functional End3p is required to localise Slalp to the cell cortex. More 
recent studies have now also demonstrated that cells lacking END3 also contain a diffuse 
Slalp-GFP localisation and an aberrant cortical actin cytoskeleton (Warren et al, in press). 
This confirms that End3p is required for localisation of Slalp to the cell cortex.
In order to ascertain whether Slalp-GFP had been lost from the cell cortex in end3-l 
mutant cells at the non-permissive temperature due to protein degradation, cells were 
incubated at the non-permissive temperature for two hours and western blotting was 
performed to detect Slalp-GFP in whole cell extracts. Full length Slalp-GFP was detected 
in whole cell extracts of both wild type and end3-l cells after a shift to the non-permissive 
temperature (data not shown), indicating that Slalp-GFP is lost from the cell cortex in 
end3-l cells at the non-permissive temperature and is not degraded.
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ENDS endJ-J
(A). Slalp-GFP
(B). Actin
30°C
37°C
30°C
37“C
Figure 3.8 End3p is required for localisation of Slalp to the cell cortex and for proper 
organisation of the cortical actin cytoskeleton. (A) Localisation of Slalp-GFP was observed 
in wild type (KAY397) and end3-l (KAY462) cells by direct fluorescence microscopy before 
and after a 2 hour incubation at the non-permissive temperature. (B) The cortical actin 
cytoskeleton was observed in fixed cells by rhodamine phalloidin staining before and after a 2 
hour incubation at the non-permissive temperature. Bar 10 pm
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3.2.9 Cells lacking SLAI or the C-terminal repeat region have defects in 
fluid phase endocytosis.
Pan Ip and EndSp have roles in endocytosis (Tang and Cai, 1996, Benedetti et al, 1994, 
Tang et al, 1997) and interactions between Slalp and End3p are required for the cortical 
localisation of Slalp. To investigate the effect of SLAI mutants on fluid phase endocytosis 
Lucifer yellow was used. Wild type cells, Aslal cells or cells expressing the slalACt 
mutant were grown to mid log phase before being assayed for their ability to endocytose 
Lucifer yellow. Lucifer yellow is a small fluorescent molecule that is used as a marker for 
fluid-phase endocytosis in yeast (see Methods and Materials 2.7.1.1; Dulic et al, 1991).
In wild type cells, Lucifer yellow accumulates in the vacuole and can be visualised by 
fluorescence microscopy. Cells either lacking SLAI or expressing slalACt are defective in 
Lucifer yellow uptake to the vacuole. About 45% of SLAI null cells and 40% of cells 
expressing slalACt did not contain Lucifer yellow in their vacuoles (Figure 3.9). Cells that 
contained vacuolar Lucifer yellow had a reduced relative intensity of vacuolar staining 
when compared to wild type cells. Both these observations suggest that fluid phase 
endocytosis is defective in SLAI mutant cells.
3.2.10 Cells lacking SLAI are defective in the internalisation step of 
endocytosis.
Cells either lacking SLAI or expressing slalACt are defective in the accumulation of 
Lucifer yellow in their vacuoles. This could be due to either a defect in the internalisation 
step of endocytosis or defects in the movement of internalised vesicles. To determine if 
these cells display a defect in the internalisation step of endocytosis, iodinated a-factor 
peptide was used (Materials and Methods section 2.4.13 and Siegel et al, 1999).
78
(A).
Wild type
Aslal
s la lA C t
s
M
Figure 3.9 Effects of the slaACt mutation upon fluid phase endocytosis. (A) Actively 
growing wild type (KAY302), Aslal (KAY300) and slalACt (KAY369) cells were 
incubated in the presence of Lucifer yellow for 1 hour. Lucifer yellow uptake was then 
visualised by fluorescence microscopy. Bar 10 fim.
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(B). Percentage of cells containing vacuolar Lucifer yellow staining.
100  1
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Relative intensity of vacuolar Lucifer yellow staining.
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Figure 3.9 Cells lacking the C-terminal repeat region of Slalp are defective in fluid- 
phase endocytosis. (B) Cell counts of cells containing Lucifer yellow in their vacuoles. 
(C) Intensity of vacuolar Lucifer yellow staining in the cells containing Lucifer yellow in 
their vacuoles.
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Wild-type cells show a rapid uptake of the iodinated a-factor peptide that peaks at about 10 
minutes (figure 3.10a) after beginning the pulse chase experiment. These cells show a 3- 
fold increase (figure 3.10b) in the internalised peptide after 10 minutes. Aslal cells show a 
slight uptake of the peptide that peaks at around 10 minutes (figure 3.10a) after beginning 
the pulse-chase experiment. These cells show a much higher starting value for peptide that 
could not be removed by a pH 1.1 wash (figure 3.10a). This may be due to either the 
peptide ‘sticking’ to the thick cell wall or due to an increase in the number of dead cells in 
the Aslal samples. Although an increase in the internalised peptide is observed in Aslal 
cells the amount taken up is much less than by wild-type cells (figure 3.10b). This data 
demonstrates that Aslal cells have defects in the internalisation step of endocytosis, 
however there is not a complete block of internalisation as an increase in the internalised 
peptide is observed.
3.2.11 Cortical actin patch components have different but overlapping 
cell fractionation patterns.
Slalp has been shown to interact with a number of different proteins involved in actin 
dynamics and endocytosis. The C-terminal repeat region interacts with the Panlp/End3p 
complex (Tang et al, 2000) and Slalp has also been shown to coimmunoprecipitate with 
LaslTp (Rong Li, 1997), Sla2p and Abplp (Warren et al, in press). To determine if these 
proteins are found in the same complex or are present in different complexes, whole cell 
extracts were spun through a 3-30 % sucrose gradient (see Methods and Materials section 
2.6.6; Yang et al, 1999). Fractions were collected from the bottom of the gradient and 
western blotting was performed to detect which fractions contained different proteins.
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F ig u i ’e  3 .1 0 .  The effects of deletion of SLAl on the internalisation step of endocytosis. 
Wild type and Aslal cells were assayed by the pulse chase protocol (see Materials and 
Methods section 2.4.13) at30°C. Cells were incubated on Y PAD plates overnight, 
resuspended and harvested by centrifugation. Iodinated a-factor peptide was allowed to 
bind for one hour. Unbound peptide was removed washing in prewarmed YPAD. (A) 
Ratio of pHl.l/pH6 wash at different time points. (B) Fold activation compared to 
starting values.
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Abplp and Sla2p displayed similar fractionation patterns (Figure 3.11) to those described 
in earlier studies (Yang et al, 1999). Only fraction 7 contained all four of the cortical actin 
patch associated proteins observed (figure 3.11). Other fractions contained different 
combinations of these proteins. For example, fraction 5 contained only Abplp and Slalp 
whereas fraction 8 contained Slalp, End3p and Slalp (figure 3.11). This data demonstrates 
that cortical actin patch associated proteins contain a varied but overlapping fractionation 
pattern.
To ascertain whether these proteins are actually present in the same complex in these 
fractions, immunoprécipitations were performed. Unfortunately this proved unsuccessful, 
probably due to the high sucrose concentrations present in the fractions interfering with the 
antibody binding.
3.2.12 Screen to identify genes that when overexpressed can rescue the 
Abplp-dependent phenotype of the slalACt mutant.
Cells lacking A5P7 and expressing the slalACt mutation are in viable, suggesting that 
Abplp and the C-terminal repeat region of Slalp contain a functional redundancy. To 
elucidate this possible functional redundancy further, the yeast 2-hybrd system was utilised 
to attempt to identify interacting partners for the C-terminal repeat region of Slalp. 
However, this technique was unsuccessful as the C-terminal repeat region of Slalp fused to 
the GAL4 binding domain plasmid self-activated in the yeast 2-hybrid system (data not 
shown). This observation has since been supported by data from other studies (Tang et al, 
2000).
Next, a screen to identify genes that when overexpressed could rescue the Abplp- 
dependent phenotype was performed (figure 3.12). A strain containing both the Aabpl and
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Abplp
Slalp
End3p-HA
Sla2p
Fraction number.
1 2  3 4 5  6 7  8 9 10 11
Figure 3.11 Fractionation of cortical actin patch associated proteins. Whole cell extracts 
of KAY476 (SLAl-myc END3-HA) were fractionated on linear 3-30% sucrose gradients. 
Fractions were collected from the bottom of the gradient. Western blotting was performed 
to identify which fractions contained various actin patch components.
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the slalACt mutations that contained a plasmid expressing full length ABPl, allowing these 
cells to be viable, was constructed. After transforming these cells with a YEpl3 yeast 
genomic library, the plasmid containing ABPl was selecting against by replica plating 
transformed cells onto media containing 5-Fluoro orotic acid (5-FOA) (See Materials and 
Methods section 2.4.12). 150 colonies that were able on media containing 5-FOA were 
picked and screened for the presence of SLAl or ABPl inserts by PCR, 116 contained 
ABPl and 25 contained SLAl. The 9 remaining plasmids were sequenced in order to 
elucidate the identity of their inserts. Unfortunately all 9 inserts were identified as 
fragments of ABPL
3.3 Discussion.
Slalp is required for the proper organisation of the cortical actin cytoskeleton in budding 
yeast (Holtzman et al, 1993). Studies using plasmid borne domain deletions of Slalp have 
shown that the domain required too rescue the aberrant actin cytoskeleton organisation and 
the temperature sensitive phenotype is different to the domain required to rescue the 
Abplp-dependent phenotype associated with the knockout. These studies identified the C- 
terminal repeat region to be required to rescue the Abplp-dependent phenotype but was 
dispensable for the aberrant actin and temperature sensitive phenotypes (Ayscough et al, 
1999). To examine if this is true when the truncated SLAl was expressed at wild-type 
levels, an integrated slalACt mutant was constructed. Expression of integrated slalACt 
rescued the temperature sensitivity associated with the knockout, cells displayed a 
relatively normal cortical actin cytoskeleton organisation but were still Abplp-dependent.
Localisation of myc tag truncated Slalp revealed that the C-terminal repeat region of Slalp 
is required for its interaction with the cell cortex. Recent studies have demonstrated an 
interaction between the C-terminal repeat region of Slalp and the N-terminus of End3p and
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Library
Transformation
— Aabpl slalACt
ABPl
5-FOA
Viable colonies
Figure 3.12 Schematic representation of the screen to identify genes that when 
overexpressed can rescue the Abplp-dependent phenotype of cells expressing the 
slalACt mutation. A strain was constructed containing both the Aabpl and 
slalACt mutations. Viability was maintained by expression of ABPl from a URA3 
marked plasmid. These cells were transformed with a LEU2 marked YEpl3 yeast 
genomic library. Colonies were replica plated onto media containing 5-FOA, 
which is toxic to cells expressing the URA genes so for cells to grow they must lose 
the URA3 marked {ABPl) plasmid. Only inserts capable of rescuing the lethal 
phenotype will produce a viable colony in the presence of 5-FOA.
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also with the LRl region of Pan Ip (Tang et al, 2000), proteins previously shown to be 
involved in endocytosis (Benedetti et al, 1994; Tang and Cai, 1996; Tang et al, 1997). 
Using a temperature sensitive allele of ENDS we were able to demonstrate that functional 
End3p is also required for the cortical localisation of Slalp suggesting that the interaction 
between the C-terminal repeat region of Slalp and End3p is required for mediating the 
cortical localisation of Slalp.
This trimeric complex of Slalp/End3p/Panlp has proposed functions in endocytosis (Tang 
et al, 2000). Mutations in both PANl and ENDS have been demonstrated to impair 
endocytosis (Benedetti et al, 1994; Tang and Cai, 1996; Tang et al, 1997). In support of 
this trimeric complex functioning in endocytosis, cells expressing slalACt were partially 
defective in fluid phase endocytosis. As there is not a complete block in endocytosis in 
these cells this indicates that either only some of the endocytic pathways have been blocked 
by this mutation or that endocytosis is still occurring but the whole process is proceeding 
less efficiently.
Our data presented here also suggests that cortical patch proteins exist in different 
complexes at the cell cortex. Cell fractionation experiments indicated that Slalp, Sla2p, 
End3p and Abplp display different but overlapping fractionation distributions. This data is 
also supported by the recent observation that Slalp and Abplp have largely separate 
localisation patterns that occasionally colocalise (Warren et al, in press). This may suggest 
that different complexes exist at the cell cortex and these can assemble and disassemble 
allowing different cellular functions to be fulfilled. Future work to investigate if these 
proteins do exist in different complexes would be to use SLAl null cell extracts in the 
cellular fractionation experiments to investigate if the fraction pattern changes. If Slalp is
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acting as a molecular scaffold protein then you would expect the fractionation patterns to 
alter when the protein is missing.
8 8
Chapter 4.
Possible Phosphorylation and Regulation of Slalp.
4.1 Background.
Slalp contains a core repeat motif of LxxQxTGGxxxPQ in its C-terminus. This repeat 
region has been proposed to contain residues that are targets of the Actin Regulating 
Kinases Ark Ip and Prklp (Zeng and Cai, 1999). Studies carried out during the course of 
this work using the yeast protein Pan Ip revealed that the threonine residue in the LxxQxTG 
motif is phosphorylated by Prklp, suggesting Prklp phosphorylation regulates Pan Ip (Zeng 
and Cai, 1999). In vitro mutagenesis also revealed that the glycine and glutamic acid 
residues present in this motif are essential for is phosphorylation by Prklp, however, the 
requirement for the leucine residue within this motif has not been addressed (Zeng and Cai, 
1999).
Earlier studies have also demonstrated that Pan Ip forms a complex with End3p (Tang et al, 
1997). End3p binds to Pan Ip at the LR2 region where several of the LxxQxTG repeats are 
present in vivo. However, in vitro kinase assays revealed that binding of End3p to Pan Ip 
prevents the phosphorylation of these motifs (Zeng and Cai, 1999), indicating a role for 
phosphorylation in the assembly/disassembly of protein complexes at the cell cortex. Slalp 
contains 5 exact copies of this motif and also another 9 motifs with the QxTG consensus 
within its C-terminal region. When this region of Slalp was fused to GST it was shown to 
be as good a substrate for Prklp as the Pan Ip repeats in vitro (Zeng and Cai, 1999).
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A number of protein phosphatases have also been reported to interact with cortical patch 
components. Most notably, Slalp and Pan Ip have been shown to interact with the yeast 
protein phosphatase-1 (PPl) Glc7p in the yeast 2-hybrid system (Tu et al, 1996; Venturi et 
al, 2000; Uetz et al, 2000), Glc7p has been implicated in a wide range of cellular processes 
and has recently been shown to localise to the presumptive bud site and to remain localised 
to the bud neck during the yeast cell cycle (Bloecher and Tatchell, 2000). This protein 
phosphatase is therefore in a position to interact with cortical patch associated proteins. 
Slalp has also been demonstrated to interact with two serine/threonine phosphatases known 
as Ppzlp and Ppz2p (Venturi et al, 2000). These phosphatases are related to Glc7p and 
have been localised to the nucleus (Clotet et al, 1996). Other studies have shown that 
Ppzlp and Ppz2p are involved in signal transduction and the yeast cells stress response 
(Posas et al, 1995).
In this chapter we provide evidence suggesting that Slalp is phosphorylated in vivo and 
that this phosphorylation may be in part due to the functions of the Actin Regulating 
Kinases Ark Ip and Prklp. Preliminary data also indicates that Slalp may be 
dephosphorylation by the yeast protein phosphatase-1 Glc7p. These data allow us to 
suggest that the functions of Slalp are regulated by cycles of phosphorylation and 
dephosphorylation.
4.2 Results.
4.2.1 Slalp is phosphorylated in vivo.
Previous studies have suggested that the threonine residue in the C-terminal repeat motif of 
Slalp is a potential target for the Actin Regulating Kinases, Ark Ip and Prklp (Zeng and
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Cai, 1999). To investigate whether Slalp is phosphorylated, HA tagged full length Slalp 
and HA-tagged SlalACtp were immunoprecipitated from whole cell extracts. Samples 
were then treated with Lambda phosphatase, a general serine/threonine phosphatase, and 
western blotting was performed to observe whether there was a size difference 
between phosphatase treated and untreated Slalp.
A mobility shift is observed between phosphatase treated and untreated samples for both 
full length Slalp (Figure 4.1a) and slalACtp (Figure 4.1b). Slalp had a molecular weight 
of about 144.5 kDa and this decreased to about 134.9 kDa after phosphatase treatment, 
suggesting that Slalp has been dephosphorylated. A mobility shift is also observed in 
samples lacking the C-terminal repeat region, slalACtp before phosphatase treatment had a 
molecular weight of about 111.4 kDa that was reduced to about 106.7 kDa after treatment. 
This data indicates that Slalp is also phosphorylated at sites outside the C-terminal repeat 
region. This data suggests that Slalp is phosphorylated in cells.
4.2.2 The Actin Regulating Kinases Arklp and Prklp potentially 
phosphorylate Slalp.
If Arklp and Prklp phosphorylate the threonine residue in the C-terminal repeat region of 
Slalp, Slalp from cells lacking ARKl and PRKl should have a different mobility compared 
to Slalp from wild type cells. To test this whole cell extracts were prepared from wild type 
and AarklAprkl, cells and western blotting was performed to observe if a mobility shift 
existed.
A small though reproducible mobility shift is observed between Slalp from wild-type cells 
and from cells lacking ARKl and PRKl (Figure 4.2). Slalp from cells lacking both ARKl 
and PRKl had an increased mobility compared to Slalp from wild-type cells, suggesting
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Slalp-HA SlalACtp-HA
Lambda
_ +  -  +  Phosphatase
Figure 4.1 Phosphorylation of Slalp. (A) Slalp-HA (KAY355) and (B) slalACtp-HA 
(KAY364) were immunoprecipitated using agarose conjugated anti-HA antibody. 
Immunoprecipitated proteins were then treated with lambda phosphatase for 30 minutes. 
Proteins were separated on a 7.5% SDS gel and western blotting was performed. HA tagged 
proteins were detected by ECL after probing with Rabbit anti-HA (1:1000) and anti-Rabbit 
HRP (1:5000). Slalp from wild-type extracts had a molecular weight of about 144.5 kDa, 
after phosphatase treatment its molecular weight was about 134.9 kDa and slalACtp from 
wild type extracts had a molecular weight of about 111.4 kDa, after phosphatase treatment 
this was reduced to about 106.7 kDa.
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Wild type Aarkl Aprkl
175kDa
Figure 4.2 Potential regulation of Slalp by the Actin Regulating Kinases Arklp/Prklp. 
To investigate if the Actin Regulating Kinases phosphorylate Slalp, whole cell extracts 
from wild type (KAY302) and Aarkl Aprkl (KAY379) cells were analysed by 
immunoblotting for Slalp. Slalp was detected by ECL after probing membranes with 
Rabbit anti-Slalp,l:100, Campbell Gourlay and Kathryn Ayscough) and anti-Rabbit- 
HRP, 1:5000, (Sigma) antibodies. A mobility shift was observed between Slalp from 
wild type cells, with a molecular weight of about 198.6 kDa, and from Aarkl Aprkl cells, 
with a molecular weight of about 192.2 kDa. This suggests that Slalp is phosphorylated 
by Arklp and Prklp.
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that it has not been modified to the same extent as Slalp from the wild type cells. Wild- 
type Slalp had a molecular weight of about 198.6 kDa whereas Slalp from cell extract 
lacking ARKl and PRKl had a reduced molecular weight of about 192.8 kDa. It was also 
noticed that Slalp from cells lacking ARKl and PRKl formed a tighter band when 
compared to Slalp from wild type cells, this may also indicate that the Slalp from these 
cells is lacking some modifications. The reduction in the molecular weight of Slalp form 
cells lacking ARKl and PRKl, about 6 kDa), was not as large as the shift observed after 
Lambda phosphatase treatment of Slalp, about 10 kDa, (Figure 4.2a), also suggesting that 
Slalp is also targeted for phosphorylation by other kinases.
4.2.3 Arklp and Prklp are required for proper localisation of Slalp.
Recent studies have revealed that the cortical actin cytoskeleton is aberrant in cells lacking 
both ARKl and PRKl (Cope et al, 1999). In these cells most of the F-actin is localised to a 
single, large clump. This clump contains the cortical actin patch associated proteins 
Abplp, Sla2p and Sac6p (Cope et al, 1999). The aberrant actin organisation in the 
Aarkl Aprkl cells is rescued by expression of PRKl from a low copy number plasmid but is 
not rescued by the expression of a kinase dead form of PRKl (Cope et al, 1999). This 
suggests that kinase activity is important for proper cortical actin cytoskeleton organisation. 
To assess the effect of Arklp and Prklp on the localisation of Slalp, mutants containing 
single Aarkl or Aprkl deletions and myc tagged SLAl were constructed. As has been 
previously reported, these cells contained a normal cortical actin cytoskeleton organisation 
and Slalp-myc localised to small punctate patches that are polarised to the buds of cells 
(Ayscough etal, 1999),
In cells lacking both ARKi and PRKl Slalp colocalises exclusively to the actin clump.
This aberrant localisation of Slalp is not rescued by a plasmid borne kinase dead PRKl
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A arkl A prkl
Kinase dead p rk l
PRKl
Figure 4.3 Sla 1 p requires the Actin Regulating Kinases Ark 1 p/Prk 1 p for its proper 
localisation. Slalp-myc and actin were localised in wild type (KAY303) and 
Aarkl Aprkl (KAY405) cells by indirect fluorescence microscopy. Myc tagged proteins 
were localised by incubating cells with rabbit anti-myc A 14 (1:100) and then anti-rabbit 
Alexa (1:200) antibodies and actin was localised by rhodamine phalloidin. Cells lacking 
the Actin Regulating Kinases contained an aberrant cortical actin organisation that was 
not rescued by expression of a kinase dead form of PRKl from a low copy number 
plasmid (KAY466) but was rescued by expression of functional PRKl expressed from a 
low copy number plasmid (KAY465). This indicates that phosphorylation by 
Arklp/Prklp is required for proper localisation of Slalp. Bar lOf/m
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gene, but is rescued by functional PRKl expressed on a low copy number plasmid (Figure 
4.3), indicating that phosphorylation is important for proper localisation of these Slalp.
4.2.4 Genetic interactions between SLAl and the Actin Regulating 
Kinases A/?Ai/P/eAi.
As the potential targets of the Actin Regulating Kinases are the threonine residues within 
each C-terminal repeat of Slalp (Zeng and Cai, 1999), we wanted to ascertain the effect of 
the deletion of ARKl and PRKl upon the localisation of slalACtp-myc. To investigate this 
we set out to construct a strain lacking ARKl and PRKl, and also expressing the slalACtp- 
myc. However, it proved impossible to generate haploid cells containing all three of these 
mutations, suggesting that this combination may be lethal to cells. To determine whether 
this was the case, AarklslalACt-myc cells were crossed with AprklslalACt-myc cells. 
Diploid cells were sporulated and the tetrads dissected. Dissected tetrads were grown on 
rich (YPAD) plates at 30°C, however, not all of the spores were viable. The lack of four 
viable colonies indicated that certain combinations of mutations were causing lethality.
All viable colonies were transferred to synthetic media, allowing selection of the 
auxotrophic genes that mark the mutations. Figure 4.4 shows a representative tetrad 
patched onto the selection plates. None of the viable colonies contained all three of the 
slalACt-myc, Aarkl and Aprkl mutations, indicating that this combination is lethal to cells. 
The slalACt-myc mutation is synthetic lethal with the Aarkl Aprkl mutations. We have 
subsequently shown that deletion of SLAl is also synthetically lethal with the Aarkl Aprkl 
mutations (data not shown).
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4.2.5 Multiple isoforms of Slalp exist in yeast cells.
The data presented so far in this chapter indicates that Slalp is phosphorylated in yeast 
cells. This suggests that multiple isoforms of Slalp may exist. To investigate whether this 
is the case, whole cell extracts of a strain expressing a HA-tagged form of Slalp were 
analysed by 2-D gel electrophoresis (See Materials and Methods section 2.6.11). Using 
this technique we were able to detect four isoforms of Slalp (Figure 4.5). The largest 
population of Slalp is toward the positive end of the drystrip, suggesting that this 
population of Slalp is phosphorylated.
In order to ascertain if any of these isoforms of Slalp were phosphorylated, whole cell 
extracts were treated with À-phosphatase before analysis by 2-D gel electrophoresis. 
However, this proved to be unsuccessful as Slalp was degraded during the phosphatase 
treatment, and no full length Slalp was detected. As Slalp isolated from cells lacking 
ARKl and PRKl displayed a mobility shift when analysed by SDS-PAGE, we decided to 
investigate whether any of the isoforms where missing from whole cell extracts prepared 
from these cells. This also proved to be unsuccessful, as the amount of Slalp present in 
whole cell extracts prepared from these cells was very low. This may have been due to the 
aberrant actin cytoskeleton arrangement in these cells. These cells contain a single clump 
of actin, to which Slalp colocalises. Whole cell extracts have to be prepared in a buffer 
containing a low ionic strength for 2-D gel electrophoresis, as the first dimension separates 
proteins due to their charge. These conditions may not have solubilised the proteins 
contained in the clump of actin, resulting in the loss of these proteins from the extract 
during centrifugation.
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Figure 4.5 Multiple isoforms of Slalp exist in yeast cells. Whole cell extracts of 
yeast expressing a HA tagged form of Slalp were analysed by 2-D gel electrophoresis. 
Western blotting was performed and membranes were probed with Rabbit-anti HA, 
1:1000, (Santa Cruz) and anti-Rabbit-HRP, 1:5000, (sigma) antibodies. Slalp-HA was 
detected by ECL. This technique detected at least four different isoforms of Slalp 
(numbered 1-4).
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4.2.6 Slalp is potentially dephosphorylated by yeast protein phosphatase- 
1 (PPl) Glc7p.
Slalp contains a variety of potential phosphorylation sites within its sequence and Slalp 
from cells lacking the actin regulating kinases has an increased mobility on an SDS-PAGE 
gel suggesting these kinases are among those that modify Slalp. To allow regulation of the 
functions of Slalp in the cell, Slalp may therefore be a target for protein phosphatases.
One candidate protein phosphatase is the yeast PPl Glc7p.
GLC7 is an essential gene in yeast cells so cannot be deleted from the genome. However a 
set of temperature sensitive point mutants exist, most of which have cell cycle defects 
(Mike Stai'k, personal communication). One mutant that does not display a cell cycle 
defect is the glc7-13 allele (Mike Stark, personal communication). To observe if GLC7 
mutants had any effect on Slalp we decided to use the glc7-13 allele. Whole cell extracts 
of wild type and glc7-13 cells were prepared from cells grown at the permissive 
temperature. Western blotting was performed to determine if a mobility shift existed 
between Slalp from the two extracts, as shown in figure 4.6. A mobility shift is observed 
for Slalp in the two cell extracts. Slalp in the glc7-13 extract has a decreased mobility 
suggesting it is slightly larger than that of Slalp in the wild type extract. Slalp from wild 
type extracts had a molecular weight of about 212 kDa whereas Slalp from extracts 
containing the glc7-13 allele had a molecular weight of about 258.8 kDa. This indicates 
that Slalp may be hyperphosphorylated in the glc7~13 mutant (Figure 4.6).
4.3 Discussion.
Within the C-terminal repeat region of Slalp exist 5 exact copies of these repeats and also 
present are a further 9 motifs with a QxTG consensus, suggesting Slalp is a likely target for 
the Prklp kinase. Slalp contains potential phosphorylation sites for other kinases, for
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Wild type glc7-13
175kDa
Figure 4.6 Potential dephosphorylation of Slalp by yeast protein phosphatase-1 
Glc7p. To assess if Slalp is targeted by Glc7p whole cell extracts of wild type 
(KAY455) and glc7-13 (KAY460) cells were analysed by immunoblotting for Slalp. 
Slalp was detected by ECL after probing with rabbit anti-Slalp (1:100) and anti-rabbit- 
HRP (1:5000) antibodies. A mobility shift was observed between Slalp from wild type, 
with a molecular weight of about 212 kDa, and glc7-13, with a molecular weight of about 
258 kDa, cells suggesting that Glc7p facilitates modification of Slalp.
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example cAMP dependent protein kinase, that lie outside the C-terminal repeat region, 
however the LxxQxTG motifs are the only phosphorylation motif identified in the C- 
terminal repeat region. This may imply that this region of Slalp is specifically targeted for 
phosphorylation by Arklp /Prklp, allowing control of the functions of Slalp. In this study 
we were able to demonstrate that Slalp is phosphorylated and that the Actin Regulating 
Kinases Arklp and Prklp contribute to this.
In this study we have demonstrated that in cells lacking both of the Actin Regulating 
Kinases Arklp and Prklp there is a complete co-localisation of Slalp with cortical actin 
structures. Studies that were undertaken during the course of this work have demonstrated 
that this is not the case in wild type cells. Analysis of Slalp-YFP and Abplp-CFP 
simultaneously expressed in live cells has revealed that these proteins are found in largely 
separate cortical actin populations that occasionally co-localise (Warren et al, in press).
This suggests that phosphorylation of the LxxQxTG motifs in Slalp and Pan Ip by 
Arklp/Prklp in cells may be required to cause dissociation of cortical actin structures. We 
have also presented data showing the importance of phosphorylation in the disassembly of 
Slalp containing actin structures. Expression of a kinase dead form of the Prklp protein in 
cells lacking ARKl and PRKl does not cause the dissociation of Slalp from actin, 
demonstrating the importance of phosphorylation in the disassociation of cortical 
complexes.
If phosphorylation is important for the dissociation of complexes at the cell cortex then it is 
likely that these proteins undergo dephosphorylation to allow them to associate to form new 
complexes. Slalp has been demonstrated to interact with members of the protein 
phosphatase-1 family, that include Glc7p, Ppzlp and Ppz2p (Tu et al, 1996; Venturi et al.
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2000). In support of this we have also provided evidence that Glc7p may dephosphorylate 
Slalp.
Future work would include in vitro kinase assays demonstrating that Arklp and Prklp are 
capable of phosphorylating a purified, bacterially expressed C-terminal repeat region 
fragment of Slalp. A kinase-dead form of prklp could be used as a negative control for 
this assay. Other future studies may focus on the phosphorylation sites that lie outside of 
the C-terminal repeat region of Slalp. These phosphorylation sites may also allow cells to 
control the association of Slalp with other binding partners. This may involve looking at 
the effects of deletions of other kinases, for example cAMP dependent protein kinase, that 
potentially target Slalp upon the actin cytoskeleton.
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Chapter 5.
Identification and Charaterisation of Slalp Interacting
Proteins.
5.1 Background.
Slalp is comprised of a multidomain structure and has been shown to interact with an 
increasing number of proteins. During the course of this study Slalp was shown to interact 
with the Panlp/End3p complex via its C-terminal repeat region (Tang et al, 2000). In 
addition Slalp has recently been shown to interact with Sla2p and Ysc84p via its 
GAP1+SH3#3 region (Hilary Dewar, unpublished data) and also with Abplp and Lasl7p, 
the yeast WASP homologue (Rong Li, 1997; Warren et al, in press).
The yeast 2-hybrid approach has been widely used to identify interactions between 
proteins. This system utilises two plasmid borne gene fusions, that are cotransformed into 
a host yeast strain containing inducible reporter genes (see Methods and Materials; James et 
al, 1996). The protein of interest (BAIT) is encoded as a gene fusion to a DNA binding 
domain of the GAL4 protein. A second protein or a library of proteins (PREY) is encoded 
as a gene fusion to a transcription activation domain. Interaction between the two proteins 
results in localisation of the transcription activation domain to the DNA of the host strain, 
activating transcription of the adjacent reporter genes generating a phenotypic signal 
(Figure 5.1).
An initial aim of this work was to identify interacting partners of the C-terminal repeat 
region of Slalp, to do this we used the yeast 2-hybrid system. However, as mentioned in 
chapter 3, this approach was unsuccessful as this region of Slalp fused to the GAL4 binding
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CfAtA Aciv.Hioo 
Dimiiiin
Prey Peptide
B a i l  P e p t id e
GAL4 Reporter Genes
F ig u r e  5 .1 .  Schematic representation of how the 2-hybrid system works. 
Interaction between the bait and prey peptides result in localisation of the activation 
domain to the GAL4 promoter, activating expression of the reporter genes.
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domain plasmid was self-activating in the yeast 2-hybrid system (Data not shown). This 
finding has subsequently been reported by other labs (Tang et al, 2000). While an 
increasing body of data exists on the interactions of the C-terminus of Slalp, little is known 
about the central region of Slalp. This region of Slalp contains two regions termed 
Homology Domains 1 and 2 (HDl and HD2), which are the regions of highest homology 
between the S.cerevisiae and homologues of Slalp identified in S.pombe, N.orassa and 
C.albicans (Figure 5.2; Ayscough et al, 1999). This could indicate that these regions of 
Slalp have some evolutionary conserved function. The 2-hybrid system was used to 
identify interacting partners to the central region of Slalp containing these conserved 
regions.
5.2 Results.
5.2.1 Yeast 2-hybrid screen using the central region of Slalp as hait.
The central region of SLAl (nucleotides 1461-2190), containing both HDl and HD2, was 
fused to the binding domain of GAL4. An outline of the yeast 2-hybrid system is shown in 
figure 5.3. The bait plasmid alone or with empty activation domain plasmid did not 
activate expression of the reporter genes when transformed into yeast strain PJ69-2A 
(Figure 5.4). The GAP1+SH3#3 region (see figure 1.6) of SLAl fused to the pGBDUC-3 
plasmid and an fragment of SLA2 fused to the pGAD plasmid that had previously been 
shown to interact in the yeast 2-hybrid system (Hilary Dewar, unpublished data) was used 
as a positive control (Figure 5.5).
Transformation of the activation domain library into the yeast strain containing the bait 
plasmid resulted in the isolation of 124 activation colonies. Plasmids were rescued and 
then retransformed into the yeast strain containing the bait plasmid to check the plasmids
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Figure 5.2.b. Sequence alignment of S, cerevisiae and S. pombe Slalp
homologues.
s . c e r e v i s i a e  
S.pombe
— MTVFLGIYRAVYAYEP-----------QTPEELAIQEDDLLYLLQKSDIDDWWTVKKRV
MANLPIIGIYKVLYSYEPQEINPGEEIPENEREISIVEDEIVCLLEKG-EDDWYLVKRNV
IGSDSEEPVGLVPSTYIEEAPVLKKVRAIYDYEQVQNADEELTFHENDVFDVFDDKDADW 
NSNDDDEEIGIVPSNYITEAEPSTKMKALYDYTQQS— VDEISFQADQTLDCYGDTDSDW 
★ " * ★★ ★★ *# #*#*** * * * # . * * •• * * • ★ * # * *
LLVKSTVSNEFGFIPGNYVEPENGSTSKQEQAPAAA-----------------EAPAATPAA
ILVG— FNNNFGLAPRNYVEGMDASSAPASQEPSASGVNAPTVSAPNSMVSPPPSFQPPS
•  i f  m i f  m
APASAAVLPTNFLPPPQHNDRARMMQSKEDQAPDEDEEG-----------------------
AAAPATSLPSDYNPPPPPPPPPAVEDQAADANEPDDYYSSGRAVSPEIPPTYTPKQADPL
*  *  * * # # #  * * *  • •  ★
 pp PAMPARPTATT ETTDATAAA
PAPPPPPPPTLPPQSTNTSQLPMPSRNVNNLGSQVNIPPPPATPSQPPRPPTNASTRSTG
VRSRTRLSYSDNDNDDEEDDYYYNSN--------------- SNNVGNHEYNTEYHSWNVTE
TSSSMAHSYDSPPSPSSPSDAYGDPNQHLKLRTDSHDDSRAYDSSSSMGNPAYEKWEVRE
lEGRKKKKAKLSIGNNK---INFIPQKGTPHEWSIDKLVSYDNEKKHMFLEFVDP— YRS
WGKKKKRTGILAINNKSIVLTFTKTMDAAQVWPVTDLVNYSSERKHVFIEFNSDSGITS
.  * # * * * # .  # *  *  *  * *  % •  i t  t  *  *  *  * * * * * * * * *  *
LELHTGNTTTCEEIMNIIGEYKGASRDPGLREVEMASKS-----------------------
LHLHASSNTNADNIIRALGDVAGSARAAGLREIAAASGSPMPKLPSDSALHRLNAASDAA 
* * * * * * * * * ^ * * # * * * * * * * * * * * *
-------------------------------------- KKRGIVQYDFMAESQDELTIKSGDKV
GVNGGRTGDYEMSTVYGDRSARAEDHKPKDSSAGQKMGTVLYDFIAEAADELTVPCANMRV
* *  *  *  * * * * * * *  * * * * * * *  # *
YILDDKKSKDWWMCQLVDSGKSGLVPAQFIEPVRD KKHTESTASGIIKSIKKNFTKS
VIVNDTASSDWWKCSVD— GKEGWPSNFIKPDTEGDAKSPPSSSKSGQGSSLSRRASKH
*  * # *  *  *  *  *  *  * *  *  * * * * * * * * * *
PSRSRSRSRSKSNANASWKDDELQNDWGSAAGKRSRKSSLSSHKKNSStoKDFPNPKKS
ESKHKRDSKHEARPES KHESHRESKSAEKDKKDKKDKKEDSKRSRSMVSKPDSSKL
* • •  * • • •  * •  * * •  *  *  *  *  *  *  *  *  I  #  #  *
iWVDRSGT FECVDAEFIGCAKGK IH LH K A N G V K IA V A A D K LSN ED LA Y V EK ITG FSLEK F 
TW TDRTGAFKVEAEFLGYSDDKIHLHKTNGVKISVPSAKM SYKDLDYVELM TGKKVYSR
* * * # #  # * * * * * *  * * * * * *  * *  # *  •  »  m it  *  *  *  *  • ♦ *  ■
riPGSSSRGTDE^PDSiaRRRRLKEOEEKERDRRLKERELYELKKARELLDEERSRLOE 
fERKKDTQKQSHDHGHÜjKSHDREKEKEKKKDR-------- EHRKHRETEEEDEGPPPQ
• • • # . % # )K'
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FDREQLTEDMMPDINNSMLRTLGLREGDIVRVMKHLDKKFGR----------- ENIASIPT
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. ****** •,**** :***:*: x-, * * .  ; ; ;
NATGN------- MFSQPDGSLNVATSPETSLPQQLLPQTTSPAQTAPSTSAET---DDAW
IMSGGEALAAPVAVPAPIPAPVAEPAPPAAPAKEWEKAPSPPATRPKSTTPQKFDDDAW
■ • • • • • * *  *  *  *  *
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ANKPVTEPPVRASSVTVEPARVTESMNKMNISEEAKKPEAPSRPRTAPIPEPEEQ-KKAP
• • • • • * *  • *  « • i r
7VAPVSSAPVSSAPAPLDPFKTGGNNILPLSTGFVMMPMITGGDMLP MQRTGGFWPQ
VEKKDAEKSVQAPIPAQPTGN ITIQNAYFTAPQPMAADPFQSPLYVQPTGFQPPP
• " # ■ *  *  #
TTFGMQSQVTGGILPVQKTGNGLIPISNTGGAMMPQTTFGAAATVLPLQKTGGGLIPIAT 
SAL PIQPTGYMQPIPVQATGYQPLMVQPTG LQPHMT GVMPQVTGVMPQMTGWPQMT
• •••* •★★*** • •  * * • * * . ★••* ★
TGGAQFPQTSFNVQGQQQLPTGSILPVQKTANGLISANTGVSMPTVQRTGGTMIPQTSFG 
G— VMPQMTGVQVQKTGAMPQQPVNYGYQVAGMQPQATGIISQPTGIRAQATGIMTQPTG 
:* :* ** *: .* * . *
VSQQLTGGAMMTQPQNTGSAMMPQTS FNAVPQITGGAMMPQTSFNALPQVTGGAM
LHTQATGMMQPTGMQPQATGIMPQATGMMQPTGMQPQVTG— IMPQS-MPMQPQMTGVQV 
• *  *  *  ★  *  *  *  .  *  *  • * * * • •  *  *  .  *  *  .
MPLQRTGGALNT FNTGGAMIPQTS FSSQAQNTGGFRPQSQFGLTLQKTGGIAPLNQNQFT 
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GGAMNTLSTG GVLQQQQPQTMNTFNTGGVMQELQMMTTFNTGGAMQQPQ------
GGQDTSFGYEQQQMYSPMQQQQQQYYGTEMQPDMGYQQPMMSNYYDPMQMQQQTPYGYNQ 
★ ★ ••  * * *
-MMNTFNTDGIMQQPQMMN TFN— TGGAMQQPQQQALQNQPT----- GFGFGNGPQQ
TGMEGYSEYGYAQPAGNMANPMSYDPVSNASLYMPSDYNQQTQPANYYDSSFGGAQGANE 
* • •  *  *  *  •  • •  * •  * * * ■  * ★  • * • •
S - RQANIFN AT AS N P FG F 
AGKKASIYQATPDNPFGF
Homology Domain-1 
Homology Domain-2
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Outline of the yeast 2-hybrid screen.
Transform bait plasmid into PJ69-2A
Transform activation domain library
Pick activation colonies
Rescue plasmids
Retransform plasmids to check activation
Sequence plasmids that reactivate expression of reporter genes
Figure 5,3 Flow chart of the yeast 2-hybrid screen
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still activated the reporter genes. Of the 124 rescued plasmids, 20 reactivated expression 
(Figure 5.4) of the reporter genes (see Methods and Materials; James et al, 1996). All of 
the activation plasmids were then sequenced and the insert was identified using the WU- 
BLAST2 search on the Saccharomyces genome database (http://genome- 
www.stanford.edu/saccharomyces). The inserts contained on the prey plasmids are listed in 
Table 5.5.
5.2.2 Summary of interacting partners of the central region of Slalp 
identified in the yeast 2-hybrid screen.
This work has identified 6 interacting partners of the central region of Slalp. The most 
abundant insert identified in this 2-hybrid screen was a fragment of Ycl034w, with 6 hits.
All of these inserts contained different but overlapping regions of YCL034w, the smallest 
insert contained amino acids 169-289 of a 354 amino acid protein. Ycl034w has an 
unknown biological function but has previously been shown to interact with Lasl7p in the 
yeast 2-hybrid system. The function of this Slalp binding partner is investigated in more 
detail later in this chapter.
Two Fragments of ZRT3 were also identified as interacting partners of Slalp in this screen, 
however, these ZRT3 fragments are to different regions of the protein that do not overlap. 
The Zrt3p protein has been shown to encode a zinc ion transporter that is found on the 
vacuolar membrane (MacDiarmid et al, 2000). Cells lacking ZRT3 have been demonstrated 
to be viable (MacDiarmid et al, 2000).
Another interacting partner identified was Ynr065cp. Two overlapping fragments of the 
central region of the protein were identified in this screen. Ynr065cp has an unknown 
biological function but is very similar in sequence to Pep Ip and Vthlp, sharing 87%
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(A). (B).
KAY568 KAY43<S
KAY582
Figure 5.4 Two-hybrid control and activation colonies. (A) Cells containing either 
pDWl (KAY438) alone or pDWl + empty pGADC-1 (KAY582) failed to activate 
expression of the reporter genes. Cells containing plasmids previously shown to interact in 
the yeast 2-hybrid (KAY568) activated the expression of the reporter genes. (B) The pGAD- 
fusion library was transformed into KAY cells expressing pGBDU-C3-HDl/2 region of 
Slalp (pDWl). Colonies growing on activation plates were struck onto fresh activation 
plates, (a) yDW105 {YCL034w\ (b) yDW109 {YSC84\ (c) yDWlOl {YDR128w\ (d) 
yDW88 {YNR065C), (e) yDW97 {ZRT3), (f) yDWl 11 {YPRlVlw), (g) yDW59 {GAL4) and 
(h) yDW102 {ADH).
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homology with these two proteins. It also shares homology with two human proteins, 
known as Sortilin-1 and Sorl-1. Sortilin-1 has been proposed to function in localising 
proteins to endosomal vesicles and Golgi (Petersen et al, 1997; 2000). Sorl-1 is a sortilin- 
related receptor that may be involved in the uptake of lipoproteins and proteases (Jacobsen 
et al, 1996). This may be relevant as Slalp is required for efficient endocytosis and 
therefore may be part of the endocytic machinery.
The other inserts contained fragments of YSC84, Y P R lllw  and YDR128w. Ysc84p has 
been shown to interact with a number of proteins including Lasl7p (Madania et al, 1999), 
the GAP1+SH3#3 region (amino acids 118-511) of Slalp (Hilary Dewar, unpublished data) 
and Sla2p (Drees et al, 2001). Yprl71w also has an unknown biological function, but has 
been reported to display a cytoskeletal localisation (Drees et al, 2001). It has also been 
reported to interact with a number of proteins including Cap Ip, Rvsl67 and Slalp in the 
yeast 2-hybrid system. This work has naiTowed down the Slalp/Yprl71wp interaction to 
involve the central region of Slalp. Ydrl28wp is predicted to contain WD repeats but has 
an unknown biological function. Yeast cells lacking either YSC84, YNRlVlw  or YDR128w 
are viable.
This screen has identified a number of proteins that were reported by previous studies to 
interact with Slalp. The data presented here refines the regions involved in these 
interactions and identifies new interacting partners of Slalp. This validates the interactions 
identified in this study. This 2-hybrid screen identified two Lasl7p interacting proteins, 
Ycl034wp and Ysc84p, that interact with the central region of Slalp. Ysc84p has also been 
demonstrated to interact with an adjacent region of Slalp, the GAP1+SH3#3 region. Slalp 
has also been shown to interact with Lasl7p by both yeast 2-hybrid and GST pull-down 
approaches (Rong Li, 1997; Warren et at, in press). This could imply that Las 17 is
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interacting with Slalp via these two proteins that interact with adjacent regions of Slalp. 
For the rest of this work we decided to focus on Ycl034wp and Ysc84p.
5.2.3 YSC84.
The YSC84 gene is located on chromosome VIII and encodes a protein containing 468 
amino acids with a predicted molecular weight of 51kDa. Ysc84p has been shown to 
interact with LaslVp (Madania et al, 1999), Ste2p (Ito et al, 2001), the yeast alpha factor 
receptor, and also the GAP1+SH3#3 region of Slalp (Hilary Dewar, unpublished data) in 
the yeast 2-hybrid system. Database searches revealed that Ysc84p contains a SH3 domain 
in its C-terminal region and the central region consists of arginine rich and aspartic acid 
rich tracts.
The region of Ysc84p demonstrated previously to interact with the GAP1+SH3#3 region of 
Slalp is different from the region identified in this screen. Work earned out by Hilary 
Dewar demonstrated that Ysc84p was interacting with the GAP1+SH3#3 region of Slalp 
via its C-terminal SH3 domain. However the region identified in this screen does not 
contain the SH3 domain of Ysc84p, suggesting multiple interactions exist between Slalp 
and Ysc84p.
5.2.4 Sequence analysis of YCL034w,
The YCL034w gene is located on chromosome III and encodes a 354 amino acid protein 
with a predicted molecular weight of 40kDa that has been shown to interact with Lasl7p in 
the yeast 2-hybrid system (Madania et al, 1999). Database searches revealed the presence 
of three predicted sequence homology domains within the sequence of Ycl034wp (figure 
5.6).
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(A). Ycl034wp.
1 15 151
HRS domain
213 305 354
GAT domain
(B). G ga lp
150 320 520 639
G A E-domain.
Figure 5.6 Schematic representation of predicted domains contained within 
Ycl034wp and Ggalp. (A) Ycl034wp contains an N-terminal HRS domain. 
Downstream of this a potential GAT domain is present. Also present in its extreme C- 
terminus exists an NPFXD motif. (B) GGA proteins Ggalp and Gga2p contain a 
similar domain structure to Ycl034wp. Ggalp contains an N-terminal VHS domain, 
downstream of this lies a GAT domain. Located in its C-terminus is a gamma adaptin 
ear (GAE) homology domain.
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Located at the N-terminal end of the protein is a predicted VHS domain, a domain that has 
been identified in a growing number of proteins involved in endocytosis and vesicle 
trafficking. This domain is about 150 residues long and contains an unknown biological 
function but is always located in the N-terminus of proteins. The VHS domain of the 
Drosophila HRS protein has been shown to interact with FYVE domains and it has been 
proposed that these domains may interact with other domains (Mao et al, 2000). The 
crystal structure of the VHS domain of Drosophila HRS and human Toml revealed that it 
consists of eight helices arranged in a superhelix (Mao et al, 2000; Misra et al, 2000). 
Comparison of the structure of the VHS domain of human Toml with the ENTH domain of 
epsin-1 (Hyman et al, 2000) revealed a conserved surface containing a net positive charge 
and other studies have proposed that this surface plays a role in membrane binding (Misra 
et al, 2000).
Other yeast proteins that are VHS-domain containing proteins include GGA proteins and 
Vps27p (Figure 5.6). The GGA proteins have been demonstrated to be involved in the 
trafficking of proteins between the trans-Golgi network and the vacuole of yeast cells (Hirst 
et al, 2000). Vps27p has also been reported to be involved in vesicle trafficking and is 
thought to control membrane trafficking through the prevacuolar/endosomal compartment 
(Raymond et al, 1992; Piper et al, 1995). Alignment of the sequence of the VHS domains 
from Ggalp, Vps27p and Ycl034wp revealed that low sequence similarity existed between 
these VHS domains (Figure 5.7). However, prediction of the secondary structure of these 
VHS domains from the GGA proteins and Ycl034wp identified the existence of multiple 
potential a-helical regions (Figure 5.8), suggesting the possibility that these VHS domains 
also form superhelical structures similar to that of the VHS domains of human Toml and 
Drosophilia HRS.
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(A). SKQGATPREA VLAIEICLVNN GDTQAAVFAL SLLDVLVI{NC GYSIHLQISR
CCCCCCCHHH HHHHHI-im-ICC CCCCHHHHHH HtmHSSSCCC CCCSSSSHHH
G galp IŒFLNDLVKR FPEQPPLRYS KVQQMILEAIEEWYQTICICH ASYKDDLQYI
HHHHHHI-IPIHC CCCCCCCCI-ÎH HHHHPIHHHHH HHHHHI-THHHC CCCCCCHtltlH
G galp NDMHICLLKYK GYTFPKVGSE NLAVLRPNDQ LRTPSELQEE QERAQAAICLE
HHHI-II-IHHCCC CCCCCCCCCC CSSSSCCCCC CCCCHHHHHH HHHHHHHI-niH
(B). Gga2p MSHPHSHSIY LSELPVRKPQ ALGNPLLRIG QRACRMSLAB PDLALNLDIA
CCCCCCCSSS SSCCCCCCCC CCCCHHHHI-m HHFmiffiHCCC CHHI-mHCCHH
Gga2p DYINEKQGAA PRDAAIALAK LINNRESHVA IFALSLLDVL VKNCGYPFHL
HHHHI-mCCCC HHHHHHHHHH HHCCCCCCCC SSHHHHHHHS SCCCCCCCCC
G galp  QISRIŒFLNE LVÎCRFPGHPP LRYSIGQRLILT AIEEWYQT ICIOISSYICND
HHHHHHHHHH HHHCCCCCCC CCHHHHHHHHIHIHHHHHHHH HCCCCCCCCC
G galp MGYIRDMHRL LKYKGYAFPKISESDLAVLK
CCmiHHHHHH HHCCCCCCCC CCCCCSSSSC
Y cl034w p MGFLSDHPHT AITETIFRIV SSRDYTLEYB LAPLIQLIICA DHNDYNYTVN 
CCCCCCCCCCCCCCCI-n-ISSSCCCCCCSSSSCCHHHHHHHCCCCCCCCCCC
Y cl034w p QEEAARALRKIGKYGNRLQQ SRTLDLLDLFISQGVKFTVM YNDDKLLQRL 
HHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHCCCCSSSSSCCCHHHHI3HH
Ycl034wp RGMATNSENS GSGEKYEPRIIIGCCAAYAIS WLNYITQNNL ENARAYSGLY
HCCCCCCCCCCCCCCCCCHHHHHHHIWIHHHPIHCCCCCCHHHHHPIHHHHH
Y cl034w p QLGQTVKQRYSKSSRSRRS 
HHCCCSSSSCCCCCSSSSCC
Figure 5.8 Comparison of the predicted secondary structure of the VHS domains of 
(A) Ggalp, (B) Ggalp and (C) Ycl034wp. All of these VHS domains contain predicted 
regions of alpha-helices (H), coils or turns (C) and p-sheet (S).
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Downstream of this VHS domain, a potential GAT domain was identified, however, no 
functional studies have been carried out and the sequence similarity with other identified 
GAT domains is very low. Functional studies have been carried out on the GAT domains 
belonging to the yeast GGA proteins. The GGA proteins (Ggalp and Ggalp) have been 
demonstrated to interact with several members of the ARF family and this interaction 
occurs via their GAT domain (Zhdankina et al, 2001). The GAT domain is thought to 
stabilise the membrane bound ARFl in its GTP bound state by disrupting the interaction 
with GAP proteins (Zhdankina et al, 2001). Further analysis of the sequence of the GGA 
proteins and Ycl034wp revealed that these proteins were divergent in their C-terminus.
The GGA proteins contain a gamma-adaptin ear (GAE) homology domain, a proposed 
protein-protein interaction domain (Hirst et al, 2000), in their C-terminal regions, whereas 
an NPFxD motif was identified at the C-terminus of Ycl034wp. NPFxD is a motif that has 
been demonstrated to interact with EH domain-containing proteins involved in endocytosis 
(Tan et al, 1996; Salcini et al, 1997; Wendland et al, 1998). This may imply that 
Ycl034wp is involved in trafficking of proteins through yeast cells, but may be involved in 
an early step of the trafficking pathway that the GGA proteins.
5.2.5 Ycl034wp-myc localises to the cell cortex via an actin cytoskeleton 
independent process.
Slalp has been demonstrated to localise to the cell cortex in small, punctate patches that 
become polarised to the bud (Ayscough et al, 1999). In order to determine if Ycl034wp 
was in a position to interact with Slalp in cells, a myc tag was integrated at the C-terminus 
of YCL034w. Indirect immunofluorescence microscopy was used to investigate the 
localisation of myc tagged Ycl034wp (see Methods and Materials; Ayscough and Drubin,
1998).
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Y cl034w p-m yc Actin
-LAT-A
+LA T-A
Figure 5.9 Localisation of Ycl034wp-myc. Actively growing Ycl034wp-myc 
(KAY514) cells were fixed and myc-tagged proteins were localised indirect fluorescence 
microscopy using rabbit A14 (1:100) and anti-rabbit FITC (1:200) antibodies (A) before 
and (C) after treatment with 200 jàA  LAT-A for 5 minutes. Half the cells were stained 
with rhodamine phalloidin and observed by fluorescence microscopy (B) before and (D) 
after treatment with LAT-A to check that the actin cytoskeleton was disrupted. Bar 10 
pM
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Ycl034wp-myc localised in small, punctate cortical patches, mainly in the mother cell 
although there was also a small amount present in the buds. Association with actin can be 
tested by incubating cells with LAT-A (Ayscough et al, 1997; Morton et al, 2000). 
Treatment with LAT-A results in actin and proteins directly associated with actin become 
disassembled and dispersed. After the actin cytoskeleton was disrupted by LAT-A, the 
localisation pattern of Ycl034wp-myc was slightly altered. Ycl034wp-myc was still 
present at the cell cortex but rather than being organised into small punctate patches it 
appeared to be more uniform through the cell cortex. This suggests that localisation of 
Ycl034wp-myc to the cell cortex does not require an intact actin cytoskeleton, however it 
requires the actin cytoskeleton to organise into discrete structures at the cell cortex (Figures 
5.9).
5.2.6 Characterisation of cells lacking YCL034w and YSC84,
Both Ycl034wp and Ysc84 were identified as Lasl7p interacting proteins in the yeast 2- 
hybrid system (Madania et al, 1999) and have also been demonstrated to interact with 
adjacent regions of Slalp (Hilary Dewar, unpublished data). This may indicate that these 
proteins function to link Slalp to Lasl7p. To investigate this possibility strains were 
constructed lacking YCL034w, YSC84 or both YCL034w and YSC84.
5.2.7 Growth of cells lacking YCL034w and YSC84.
Cells lacking either YCL034w or YSC84 displayed no noticeable growth defect at 30°C or 
31°C on YPAD plates (Figure 5.10). However cells lacking both of these genes display a 
slow growth defect at 30°C and are not viable at 37°C. This synthetic lethality at elevated 
temperatures suggests that these proteins may have overlapping functions in yeast cells.
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(A). 30“C
Wild i\ pc
(B). 37”C
t  ' * 4  i
Avcl034\\'
Figure 5.10 Growth of mutant strains on YPAD plates. (A) Wild type (KAY302), 
Aysc84 (KAY510), Aycl034w (KAY515) and Aysc84Aycl034w (KAY516) cells were 
struck out on YPAD plates and incubated at 30°C for 2 days. (B) Wild type (KAY302), 
Aysc84 (KAY510), Aycl034w (KAY515) and Aysc84Aycl034w (KAY516) cells were 
struck out on YPAD plates and incubated at 37“C for 2 days.
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5.2.8 Cells lacking YCL034w and YSC84 contain an aberrant cortical 
actin cytoskeleton organisation.
Ysc84p and Ycl034wp have been shown to interact with Lasl7p in the yeast 2-hybrid 
system (Madania et al, 1999) and Lasl7p is the yeast WASP homology that has been 
shown to stimulate the actin nucléation activity of the Arp2/3 complex. Ycl034wp and 
Ysc84p could therefore be in a position to link Slalp to actin dynamics. Rhodamine 
phalloidin was used to observe the effects of deleting these genes from the cells on the 
cortical actin cytoskeleton organisation (see Methods and Materials and Pringle et al,
1989).
Wild-type cells contained small, punctate cortical actin patches that are highly polarised 
and are found throughout the cortex of the bud in small-medium budded cells (Figure 
5.11a). Cells lacking either YSC84 or YCL034w contained a normal cortical actin 
cytoskeleton organisation. However, cells lacking both YSC84 and YCL034w contained an 
aberrant cortical actin organisation. In about 70 % of these cells the cortical actin patches 
were depolarised and found throughout the cortex of mother cells of small-medium budded 
cells (Figure 5.11b). These cells appeared to contain fewer cortical actin patches than wild 
type or cells lacking either YCL034w or YSC84.
5.2.9 Sensitivity to the actin cytoskeleton disrupting drug LAT-A.
LAT-A is a drug that has been previously shown to disrupt the yeast actin cytoskeleton by 
binding to actin monomers and preventing the assembly step in a rapid cycle of assembly 
and disassembly (Ayscough et al, 1997, Morton et al, 2000). Comparing different mutants 
sensitivity to LAT-A suggests roles for proteins in stabilising or destabilising actin 
filaments.
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(A). Wild type (B). Isycl034w (C). Aysc84
IniM
2mM
•  •
(D).
Wild type Aycl034w Aysc84
Figure 5.12. Sensitivity of Ayci034w and Aysc84 cells to LAT-A, Halo assays were 
used to assess the sensitivity of cells lacking either YCL034w or YSC84. Concentrations 
measured 1 mM, 2 mM and 5 mM. (A) Wild type (KAY447), (B) Aycl034w (KAY479) 
and (C) Aysc84 (KAY510.1). (D) Comparison of the apparent sensitivity of wild type 
(KAY302), Aysc84 (KAY510.1) and Aycl034w (KAY479) as described in Methods and 
Materials section and Reneke et al, 1988).
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To assess the effect of Ycl034wp and Ysc84p on actin cytoskeleton dynamics, halo assays 
were performed on strains lacking genes encoding these proteins (Figure 5.12). Cells 
lacking YSC84 are less sensitive to the effects of LAT-A than wild-type cells indicating that 
the protein encoded by this gene acts to decrease actin filament stability. Cells containing 
the YCL034w deletion displayed a similar sensitivity to the effects of LAT-A as wild-type 
cells suggesting that Ycl034wp functions do not effect the stability of actin filaments. The 
sensitivity of the double knock out cells was unable to be determined as these cells grow 
very slowly at 30°C. After incubating plates for a week at this temperature, a lawn of cells 
was visible however no halos were observed, probably due to degradation of the LAT-A
5.2.10 Cells lacking both YCL034w and YSC84 display defects in fluid 
phase endocytosis.
Ycl034wp and Ysc84p have been demonstrated to interact with proteins involved in 
endocytosis. In this study we have shown that cells lacking YCL034w and YSC84 display 
an aberrant cortical actin organisation. Previous studies have demonstrated that defects in 
the cortical actin cytoskeleton often lead to defects in endocytosis.
To examine if cells lacking YCL034w and YSC84 had defects in fluid phase endocytosis, 
the small fluorescent molecule Lucifer yellow was used (see Methods and Materials; Dulic 
et al, 1991). Lucifer yellow is rapidly endocytosed to the vacuole in wild-type cells (Figure 
5.13a). Cells lacking either YCL034w or YSC84 rapidly accumulated Lucifer yellow in 
their vacuoles. Cells lacking both YCL034w and YSC84 were severely defective in fluid 
phase endocytosis. In these cells there is an almost complete block in the accumulation of 
Lucifer yellow, only 6 % of these cells contained Lucifer yellow in the vacuoles, indicating 
fluid phase endocytosis is severely impaired (Figure 5.13b).
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(A)
Wild type
Aycl034w
Aysc84
Aysc84
Aycl034w
(B) M
I
0)
i a
| 1CL >
Percentage of cells containing vacuolar Lucifer yellow.
Wild type Aycl034w Aysc84 Aycl034w 
Aysc84
Figure 5.13 Fluid phase endocytosis. (A) Lucifer yellow was used to assess fluid phase 
endocytosis in wild type (KAY302), Aycl034w (KAY515), Aysc84 (KAY510) and 
Aycl034wAysc84 (KAY516) cells. Actively growing cells were incubated at room 
temperature for one hour in the presence of Lucifer yellow before visualisation by 
fluorescence microscopy. (B) Percentage of cells containing vacuolar Lucifer yellow 
staining. Bar 10 pm
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5.2.11 Characterisation of cells lacking YCL034w and either SLAl or 
ABPL
Loss of both YCL034w and YSC84 results in a depolarised cortical actin cytoskeleton 
organisation and a severe block in endocytosis observed in these cells. To study functions 
of YCL034w further, we decided to study other possible genetic interactions of this gene 
with genes encoding other proteins involved in actin dynamics. To investigate the possible 
genetic interactions of YCL034w, cells lacking YCL034w in combination with either SLAl 
or ABPl were constructed. However, neither Aycl034w and Aslal or Aycl034w and Aabpl 
showed any synthetic lethality. To investigate the effects of these mutations further the 
phenotypes were analysed.
5.2.12 Organisation of the actin cytoskeleton in cells lacking YCL034w in 
combination with SLAl or ABPL
Slalp is required for the proper organisation of the cortical actin cytoskeleton (Holtzman et 
al, 1993; Ayscough et al, 1999) and shares a functional redundancy with Abplp, loss of 
both of these proteins from cells is lethal. To observe the effects on cells lacking YCL034w 
in combination with either deletion of SLAl or ABPl on the organisation of the cortical 
actin cytoskeleton, rhodamine phalloidin was used (See Materials and Methods; Pringle et 
al, 1989).
Wild type cells contain small punctate cortical actin patches that are highly polarised. As 
described previously, loss of ABPl had little effect on the cortical actin cytoskeleton, 
whereas loss of SLAl results in an aberrant cortical actin cytoskeleton morphology, these 
cells contain fewer cortical chunks of actin (Holtzman et al, 1993; Ayscough et al, 1999). 
Cells lacking both YCL034w and ABPl displayed a relatively normal cortical actin (Figure
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5.14) cytoskeleton. Loss of both YCL034w and SLAl from cells causes an aberrant cortical 
actin cytoskeleton morphology similar to that of cells lacking just SLAL
5.2.13 Fluid phase endocytosis in cells lacking YCL034w in combination 
with 5LAi or ABPl,
Slalp contains a multidomain structure and has been shown to interact with the 
Panlp/End3p complex to play roles in endocytosis (Tang et al, 2000). Cells either lacking 
SLAl or expressing slalACt are defective in fluid phase endocytosis, although there is not a 
complete block of the process (See Figure , Chapter 1). Abplp has also been shown to 
interact with components of the endocytic machinery, such as the yeast homologue of 
Amphiphysin Rvsl67p, in the yeast 2-hybrid system (Lila and Drubin, 1997; Col will et al, 
1999; Drees et al, 2001).
To investigate the effects of deletion of YCL034w and SLAl or YCL034w and ABPl on 
fluid phase endocytosis, the small fluorescent molecule Lucifer yellow was used (see 
Materials and Methods; Dulic et al, 1991). As reported previously, cells lacking YSC84 or 
ABPl rapidly accumulated Lucifer yellow in their vacuoles (Hilary Dewar, unpublished 
data; Wesp et al, 1997), whereas cells lacking SLAl displayed a partial block in the 
accumulation of Lucifer yellow in their vacuoles (Chapter 1, Figure 1.2.). Cells lacking 
YCL034w and ABPl displayed no obvious defect in fluid phase endocytosis (Figure 5.15). 
Deletion of YCL034w and SLAl resulted in a partial block in fluid phase endocytosis that 
appeared very similar to that displayed by SLAl null cells. This suggests that Slalp 
function lies upstream of Ycl034wp function and that Abplp plays no role in the functions 
of Ycl034wp.
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5.3 Discussions.
Slalp has been shown to interact with a number of different proteins. The GAP1+SH3#3 
region has been demonstrated to interact with both Sla2p and Ysc84p in the yeast 2-hybrid 
system (Hilary Dewar, unpublished data). Studies on the C-terminal repeat region of Slalp 
using both yeast 2-hybrid and immunoprécipitation approaches have demonstrated 
interactions with the Panlp/End3p complex (Tang et al, 2000).
While a lot of data exists on the interactions of the C-terminus of Slalp, little is known 
about the central region of Slalp. This part of the protein contains two regions that show 
the highest sequence identity to the S. pombe Slalp homologue which may suggest that 
these regions may have some evolutionary conserved function (Ayscough et al, 1999). To 
shed light on the function of the central region of Slalp the yeast 2-hybrid system was 
utilised to identify interacting partners of this region.
The most frequent interacting partner identified was Ycl034wp, a protein that has also been 
demonstrated to interact with Lasl7p in the yeast 2-hybrid system (Madania et al, 1999). 
Little is known about the functions of Ycl034wp but database searches identified three 
distinct domains within the protein, an N-terminal VHS domain, a central GAT domain and 
a C-terminal NPFxD motif. Another Lasl7p interacting protein, Ysc84p (Madania et al,
1999), was also shown to interact with the central region of Slalp. This protein has also 
been demonstrated to interact with the GAP1+SH3#3 region of Slalp via its C-terminal 
SH3 domain (Hilary Dewar, unpublished data)..
Slalp has been shown to interact with Lasl7p by both GST pull down and 
immunoprécipitation approaches (Li, 1997; Warren et al, in press). Two Lasl7p
133
interacting proteins have been demonstrated to interact with adjacent regions of Slalp, 
suggesting they are linking Lasl7p to Slalp. Slalp could be acting as an adaptor protein 
linking the endocytic machinery, via interactions with the Panlp/End3p complex, to actin 
dynamics, via interaction with Ycl034wp and Ysc84p. Deletion of either YCL034w or 
YSC84 had no observable effect on yeast cells. However cells lacking both YCL034w and 
YSC84 had a depolarised cortical actin cytoskeleton and were defective in fluid phase 
endocytosis.
Ysc84p has been demonstrated to colocalise with cortical actin patches (Hilary Dewar and 
Kathryn Ayscough, unpublished data). Charaterisation of cells lacking YSC84 revealed that 
these cells are less sensitive to the effects of LAT-A than wild type cells suggesting that 
Ysc84p decreases actin filament stability. This implies that Ysc84p is involved in 
processes that require cortical actin patches.
The localisation pattern of Ycl034wp does not resemble that of the cortical actin patches. 
Deletion of YCL034w had no noticable effect upon the yeast cells sensitivity to LAT-A, 
This suggests that Ycl034wp has no direct role in the functions of cortical actin patches. 
However, this protein contains three predicted domains that indicate a role for this protein 
in endocytosis and vesicle trafficking. So far no functional studies have been carried out on 
these domains but the GAT domain may potentially allow Ycl034wp to interact with 
vesicular membranes via interactions with the ARF family proteins.
Arfs are members of the Ras-GTPase superfamily that have been implicated in the 
regulation of vesicle trafficking and the actin cytoskeleton in mammalian cells. Studies 
carried out using Arf6 have demonstrated that this protein is found at the plasma membrane 
and its overexpression leads to alterations in the actin cytoskeleton (Radharkrishna et al,
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1996; D’souza-Schorey et al, 1998). More recently an activated form of Arf6 has been 
shown to induce actin assembly that resulted in the movement of vesicle-like particles 
(Schafer et al, 2000). This particle motility induced by Arf6 was also demonstrated to 
involve the Arp2/3 complex (Schafer et al, 2000). These data indicate a role for Ycl034wp 
in linking vesicular structures to actin dynamics via interactions with the Arf family 
proteins and Lasl7p.
Deletion of YCL034w or YSC84 from cells lead to no obvious phenotype, however, cells 
lacking both YCL034w and YSC84 display an aberrant cortical actin cytoskeleton 
morphology and a severe block in fluid phase endocytosis. As these two proteins may 
potentially have different cellular functions this suggests that multiple stages of the 
endocytic pathway may be defective in cells lacking both these proteins. These defects 
could be due to multiple stages of the endocytic pathway becoming uncoupled from 
proteins involved in actin dynamics.
We also provide evidence that Slalp function lies upstream of Ycl034wp function as cells 
lacking both YCL034w and SLAl display a cortical actin cytoskeleton organisation and 
endocytic defects that resemble those of SLAl null cells. However, Abplp appears to 
contain no overlapping functions with Ycl034wp as cells lacking both YCL034w and ABPl 
display no obvious phenotypes.
Future work to elucidate further the cellular role of Ycl034wp would include determining 
whether it is associated with vesicular membranes by cell fractionation experiments. 
Identifying interacting partners for this protein may also determine the cellular functions of 
this protein. One candidate interacting protein is the yeast homologue of Arf6 (Arf3p) and 
may potentially be a candidate for allowing yeast cells to control endocytosis.
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Chapter 6. 
Final Discussion.
6.1 Aims of this project.
Previous studies have suggested that the C-terminal repeat region of Slalp is required to 
rescue the Abp 1 p-dependent phenotype associated with SLAl knockout cells (Ayscough et 
al, 1999). To further our understanding of the roles and interactions of this region, a strain 
lacking the entire C-terminal repeat encoding sequence was constructed.
It has previously been reported that the C-terminal repeat region of Slalp contains motifs 
that are a potential target for the Actin Regulating Kinases (Zeng and Cai, 1999). These 
kinases may regulate the functions of Slap through phosphorylation of residues within these 
motifs. This study aimed to determine whether the C-terminal repeat region is 
phosphorylated and to expand our knowledge of how the functions of Slalp are regulated in 
vivo.
The final aim of this study was to identify interacting partners of Slalp, using the yeast 2- 
hybrid system. Elucidation of Slalp interacting proteins may allow a better understanding 
of how Slalp fulfils its functions at the cell cortex.
6.2 Findings of this study.
Characterisation of the integrated slalACt mutant demonstrated that these cells were viable 
at high temperatures, displayed a relatively normal actin cytoskeleton organisation and
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required expression of ABPl for viability. The data presented in Chapter 3 demonstrates 
that the C-terminal repeat region of Slalp is required to localise the protein to the cell 
cortex. This study has also demonstrated, using a temperature sensitive allele of ENDS, 
that End3p is also required to localise Slalp to the cells cortex. This is in line with a 
previous study which demonstrated that Slalp is able to interact with the Panlp/End3p 
complex (Tang et al, 2000). Data presented in Chapter 3 also suggests a role of Slalp in 
endocytosis. Cells either lacking SLAl or expressing the slalACt mutation were partially 
defective in fluid phase endocytosis. Further analysis of SLAl null cells, using radio­
labelled alpha factor peptide indicates that these cells are partially defective in the 
internalisation step of endocytosis.
Chapter 4 is concerned with the possible phosphorylation and regulation of Slalp. The data 
presented here demonstrates that Slalp is phosphorylated in vivo. It suggests there are 
multiple phosphorylation sites both within the C-terminal region and out with this domain. 
This work also provides evidence suggesting that Slalp is phosphorylated by the Actin 
Regulating Kinases and that phosphorylation of Slalp by these kinases is required for its 
proper localisation. In combination the Aarkl, Aprkl, and slalACt mutations are 
synthetically lethal, further indicating the importance of these proteins. Data presented in 
the final part of this chapter also indicates that Slalp may potentially be dephosphorylated 
by the yeast Protein Phosphatase-1 Glc7p. This indicates that the functions of Slalp may 
be regulated by cycles of phosphorylation and dephosphorylation.
In this study, the yeast 2-hybrid system has also been utilised to determine novel interacting 
partners of Slalp. Originally, this study attempted to identify interacting partners for the C- 
terminal repeat region of Slalp. Unfortunately, this proved impossible as this region fused 
to the GALA binding domain is self-activating in the yeast 2-hybrid system.
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The central region of Slalp contains two regions that share the highest homology between 
the Slalp homologues, suggesting that this region may contain some evolutionary function. 
In Chapter 5, the interacting partners identified in this study for the central region of Slalp 
are presented. This screen identified novel interacting partners including Ycl034wp and 
Ynr065cp as well as previously reported interacting partners such as Ysc84p and 
YprlTlwp (Drees et al).
The remaining part of chapter 5 concentrates upon the cellular roles of Ycl034wp. The data 
presented here demonstrates that Ycl034wp is localised in small, punctate cortical patches 
that were found in both the mother cell and the bud. This work also indicates that 
localisation of Ycl034wp is an actin independent process. This study also demonstrates 
that cells lacking either Ycl034wp or Ysc84p display no obvious phenotypes. However, 
cells lacking both Ycl034wp and Ysc84p are temperature sensitive, display an aberrant 
cortical actin cytoskeleton organisation and have a severe block in fluid phase endocytosis. 
To further analyse the role of Ycl034wp, mutants lacking both YCL034w and SLAl or 
YCL034w and ABPl were charaterised. Data presented here shows that cells lacking 
YCL034w and SLAl display phenotypes similar to SLAl null cells whereas cells lacking 
both YCL034w and ABPl display no obvious phenotype. This suggests that the function of 
Slalp lies upstream to the function of Ycl034wp in yeast cells.
6.3 Slalp interacts with components of the endocytic 
machinery.
In these studies we have demonstrated that the C-terminal repeat region of Slalp is required 
for its localisation to the cell cortex. Data presented in this work also demonstrates that 
functional End3p is required for the cortical localisation of Slalp, suggesting that the
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interaction between the C-terminal repeat region of Slalp and End3p is required to mediate 
localisation of Slalp to the cell cortex. Data presented here also shows cells either lacking 
SLAl or expressing slalACt displayed a paitial block in fluid phase endocytosis. Further 
analysis of Aslal cells demonstrated that these cells have a partial block in the 
internalisation step of endocytosis (Warren et al, in press). This supports previous studies 
suggesting that the Slalp/End3p/Panlp complex plays roles in endocytosis (Tang et al, 
2000).
6.4 Slalp interacts with proteins that may play roles in vesicle 
trafficking.
Using the central region of Slalp as bait, this study identified Ycl034wp and Ynr065cp as 
proteins that interact with Slalp. Sequence analysis revealed that Ycl034wp contains a 
predicted VHS domain at its N-terminus. VHS domains have been identified in a growing 
number of proteins involved in vesicle trafficking. This domain has an unknown function, 
however, a number of potential functions have been proposed. The VHS domain of the 
Drosophila HRS protein has been shown to interact with FYVE domains and it has been 
proposed to be protein-protein interaction module (Mao et al, 2000). Another possibility is 
that VHS domains are involved in membrane binding. Comparison of the structures of the 
VHS domain from human Toml with the ENTH domain of epsin revealed a conserved 
surface containing a net positive charge that may be able to interact with membranes 
(Hyman et al, 2000; Misra et al, 2000). Also present in Ycl034wp is a predicted central 
GAT domain. Although no functional studies have been carried out on the predicted 
domains identified in Ycl034wp and the homology shared with other GAT domains is very 
low, this region may potentially link Ycl034wp to the ARF family proteins. This would 
implicate Ycl034wp in the process of vesicle trafficking.
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Ycl034wp has been reported to interact with Lasl7p in the yeast 2-hybrid system (Madania 
et al, 1999). This may suggest that Ycl034wp is functioning to link proteins involved in 
actin dynamics to vesicle transport. Ycl034wp has the potential to interact with GTP- 
bound ARF family members via the predicted GAT domain. This may allow yeast cells to 
regulate Lasl7p and allow actin dynamics to move a vesicle. Studies in mammalian cells 
support a role for the Arf family proteins in regulating Arp2/3 dependent actin 
polymerisation (Schafer et al, 2000).
This study also identified Ynr065cp as an interacting partner of Slalp. Although very little 
is known about this yeast protein, its mammalian homologues (Sortilin-1 and Sorl-1) have 
been implicated in vesicle trafficking (Jacobsen et al, 1996; Petersen et al, 1997; 2000). 
This implicates the central region of Slalp in the vesicle trafficking. Slalp may be a 
potential docking site at the cell cortex for proteins involved in vesicle transport. In 
agreement with this, vesicles accumulate in Aslal cells (Kathryn Ayscough, unpublished 
data).
6.5 Slalp interacts with proteins involved in actin dynamics.
The screen carried out in this study identified Ysc84p as an interacting partner of the 
central region of Slalp. Other studies have demonstrated that Ysc84p localises to cortical 
actin patches and that proper localisation of Ysc84p requires an intact cortical actin 
cytoskeleton (Hilary Dewar and Kathryn Ayscough, unpublished data). Data presented in 
Chapter 5 suggests that Ysc84 plays roles in actin dynamics, cells lacking YSC84 are less 
sensitivity to the effects of LAT-A, suggesting that Ysc84p decreases actin filament 
stability. These data indicate that Ysc84p is an actin patch associated protein that may play 
roles in actin dynamics.
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Other work has demonstrated that Slalp interacts with both Lasl7p and Abplp (Li, 1997; 
Warren et al, in press), proteins that have been shown to interact with and stimulate the 
actin nucleating activity of the Arp2/3p complex (Winter et al, 1999; Goode et al, 2001). 
The domains within Slalp responsible for this interaction have not been elucidated, 
however, given that cells expressing SLAl lacking the GAP1+SH3#3 region display an 
aberrant actin phenotype (Ayscough et al, 1999), it would imply that these proteins interact 
with Slalp via this domain,
6.6 A model for Slalp function in linking actin dynamics to the 
endocytic machinery and vesicle trafficking.
Data from this study and from other studies have demonstrated that Slalp interacts with 
proteins involved in actin dynamics, components of the endocytic machinery and also 
proteins that may be involved in vesicle transport. The simplest model is that Slalp is 
functioning as an adaptor protein that assembles with the endocytic machinery and recruits 
proteins that are activators of actin dynamic turnover to the proper sites promoting 
endocytosis and allowing efficient vesicle trafficking to occur (figure 6.1).
In support of this model, Slalp has been reported to interact with both Lasl7p (Li, 1997; 
Warren et al, in press) and Abplp (Warren et al, in press). Both of which have been 
demonstrated to stimulate the activity of the Arp2/3 complex (Winter et al, 1999; Goode et 
al, 2001). Pan Ip has also been reported to interact with the Arp2/3 complex via an acidic 
region within its sequence (Duncan et al, 2001). Although the authors suggest that Pan Ip 
is also able to stimulate the nucleating activity of the Arp2/3 complex, their data did not 
show a reduction in the lag phase of actin polymerisation by adding increasing amounts of 
Pan Ip to purified Arp2/3 complex in vitro. An alternative model to that suggested by 
authors is that the interaction between Pan Ip and the Arp2/3 complex serves to stabilise the
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whole assembled complex. This may allow Lasl7p and Abplp to stimulate the nucleating 
activity of the Arp2/3 complex at sites that are in close proximity to the endocytic 
machinery, promoting endocytosis.
In these studies we have demonstrated that central region of Slalp interacts with Ycl034wp 
and Ysc84p. Other work has shown that Ysc84p also interacts with the GAP1+SH3#3 
region of Slalp via a C-terminal SH3 domain (Hilary Dewar and Kathryn Ayscough, 
unpublished data). Both Ycl034wp and Ysc84p have been demonstrated to interact with 
Lasl7p in the yeast 2-hybrid system (Madania et al, 1999), suggesting that both of these 
proteins may link Slalp to actin dynamics via Lasl7p. However, the data presented here 
suggests that Ycl034wp and Ysc84p may play roles during different stages of the endocytic 
process. Ycl034wp may potentially contain domains that allow it to function in vesicle 
trafficking, whereas Ysc84p may be playing roles in actin dynamics at the cell cortex.
Although Lasl7p has been demonstrated to interact with other proteins involved in 
endocytosis, such as Rvsl67p, it is not known if these interactions are direct. If Ysc84p 
and Ycl034wp play roles in different stages endocytosis, they may allow Lasl7p to be 
linked to different stages of endocytic pathway. Identifying functions and interacting 
partners of Ysc84p and Ycl034wp may be useful in furthering our understanding of how 
these proteins are involved in actin regulation and endocytosis.
6.7 Regulation of the assembly and disassembly of protein 
complexes at the cell cortex.
Other studies have demonstrated that Slalp associates with a subset of cortical actin 
containing patches (Warren et al, in press). This is evidence that the distribution of cortical 
patch associated proteins do not always overlap. Data presented in this work demonstrates
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that the cell fractionation patterns of the cortical actin patch proteins Slalp, Slalp. Abplp 
and End3p were different but overlapping. This is further evidence that cortical actin patch 
proteins do not exclusively colocalise. These data imply that the assembly/disassembly of 
complexes at the cell cortex is regulated.
The Actin Regulating Kinase Prklp has been shown to phosphorylate a region of Pan Ip 
comprised of multiple copies of the LxxQxTG motif (Zeng and Cai, 1999). The C-terminal 
repeat region of Slalp contains 5 exact copies of this repeat, but also contains a further 9 
copies of the QxTG motif suggesting that Slalp is a likely target for the Prklp kinase.
Using wild type cells and cells lacking both ARKl and PRKl we were able to show that 
Slalp may be phosphorylated by these Actin Regulating Kinases.
In cells lacking both Ark Ip and Prklp we were able to demonstrate that Slalp is localised 
exclusively too the aberrant chunk of actin present in these cells. However, a recent study 
carried out during the course of this work demonstrated that Slalp does not exclusively 
localise to actin patches in wild type cells (Warren et al, in press). This suggests that 
phosphorylation of cortical patch associated proteins leads to the disassembly of cortical 
Slalp containing structures. We have also demonstrated the requirement for 
phosphorylation in the disassembly of Slalp containing structures. Expression of functional 
Prklp, but not kinase dead form of the Prklp, in cells lacking both ARKl and PRKl 
resulted in the disassembly of the large, aberrant actin chunk (Cope et al, 2000) and 
uncoupled the Slalp patches from actin patches.
There is increasing evidence that phosphorylation is a common regulatory mechanism of 
the cortical actin patch associated proteins. A recent study has demonstrated that the yeast 
Epsin homologues, Entlp and Ent2p, are also targets of the Actin Regulatory Kinases
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Arklp/Prklp (Watson et al, 2001). Both Entlp and Ent2p are cortical actin patch 
associated proteins that contain 2 copies of the L/IxxQxTG motif (Watson et al, 2001). 
Sequence analysis has also revealed that both Lasl7p and Arp2p contain 1 copy of the 
LxxQxTG motif, suggesting that these proteins are also potentially regulated by the actin 
regulating kinase Arklp/Prklp.
More recently the Actin Regulating Kinases have been shown to interact with the SH3 
domain of Abplp and this interaction is required to localise these kinases to the actin 
patches (Fazi et al, 2001). Abplp completely colocalises to the cortical actin patches 
whereas Slalp localisation only partially overlaps with the actin patches. This led to the 
hypothesis that Abplp localises Arklp/Prklp to the cortical actin patch, where they can 
function to disassembly structures via phosphorylation of QxTG motifs.
As phosphorylation appears to be important for the disassembly of cortical complexes then 
it is likely that these proteins also are dephosphorylated, allowing them to assemble into 
new complexes. In support of this, both Slalp and Pan Ip have been shown to interact with 
the protein phosphatase-1 Glc7p in the yeast 2-hybrid system (Tu et al, 1996; Venturi et al, 
2000; Uetz et al, 2000). Using wild type and cells expressing the glc7~13 temperature 
sensitive allele we were able to demonstrate that Glc7p may dephosphorylate Slalp.
The data presented in these studies suggest that the cortical patch protein Slalp undergoes 
cycles of phosphorylation and dephosphorylation allowing the assembly/disassembly of 
cortical structures. The identification of different Slalp and Abplp containing patch 
populations at the cell cortex (Warren et al, in press) implies that different protein 
complexes exist at the cells cortex. In support of this, in this study we present data showing
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that cortical patch associated proteins display different but overlapping fractionation 
patterns.
6.8 Linking actin dynamics to the endocytic machinery in 
higher eukaryotes.
To date no known mammalian homologue of Slalp has been identified, however, there is 
increasing evidence for links between actin dynamics and endocytosis in mammalian cells. 
There is now evidence that the mammalian proteins Intersectin and mAbpl function to link 
actin dynamics to endocytosis in a similar manner that we propose for Slalp. Intersectin-s 
functions as a scaffold protein in the formation of endocytic vesicles. It contains an EH 
domain that has been demonstrated to target the protein to clathrin coated pits (Hussain et 
al, 1999) and multiple SH3 domains that recruit dynamin to these endocytic stinctures 
(Sengar et al, 1999). The neural variant Intersectin-I, an alternatively spliced form of 
intersectin-s, includes a C-terminus Dbl homology (DH) domain in tandem with a 
pleckstrin homology (PH) domain. The DH domain has been shown to function as a 
guanine nucleotide exchange factor for Cdc42p (Hussain et al, 2001), a small GTP-binding 
protein that has been shown to be involved in regulating actin cytoskeleton rearrangements 
(for review see Nobes and Hall, 1995).
A recent study has demonstrated that stimulation of Cdc42p with Intersectin-I accelerates 
actin assembly via N-WASP and the Arp2/3 complex. N-WASP binds directly to 
Intersectin-I and this has been shown to stimulate the GEE activity of Intersectin-I, 
promoting the formation of GTP bound Cdc42p (Hussain et al, 2001). Cdc42p has been 
demonstrated to be a critical activator of N-WASP. These data suggest that Intersectin-I 
stimulates actin assembly in an N-WASP dependent manner. Intersectin-I has also been 
shown to interact with Eps 15 (Sengar et al, 1999), the mammalian homologue of Pan Ip, so
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Intersectin is able to interact with both components of the endocytic machinery and proteins 
involved in actin dynamics.
There are also examples of actin-binding proteins that are able to interact with components 
of the endocytic machinery, forming a direct link between the actin cytoskeleton and the 
endocytic machinery. The mammalian homologue of Abplp (mAbpl) has been shown to 
interact with and stimulate the nucleating activity of the Arp2/3p complex (Winter et al, 
1999; Goode et al, 2001). mAbpl has also recently been shown to bind dynamin (Kessels 
et al, 2001), a key GTPase involved in the formation of endocytic vesicles (Sever et al,
2000). Work by Kessels and others has also demonstrated that mAbpl is enriched at the 
sites of endocytosis (Kessels et al, 2001).
This model proposed for the function of Intersectin-I is similar to the model we propose for 
the function of Slalp, Both proteins are proposed to interact with the endocytic machinery 
via Panlp/Epsl5p (Sengar et al, 1999; Tang et al, 2000). In mammalian cells Eps 15 has 
been shown to interact with the AP-2 complex and is necessary for the formation of clathrin 
coated pits (Benmerah et al, 1995; 1998; 1999; Delft et al, 1997). Both Slalp and 
Intersectin have been shown to interact with proteins involved in actin dynamics through 
Las 17p/N-WASP, which have in turn been shown to interact with and stimulate the 
nucleating activity of the Arp2/3 complex (Madania et al, 1999; Winter et al, 1999; 
Machesky and Insall, 1998; Yarar et al, 1999).
The models differ in the requirement for GTP-bound Cdc42p, the critical activator of N- 
WASP. Lasl7p does not possess a GTPase-binding domain (Symons et al, 1996) 
indicating that is a fundamental difference between yeast and higher eukaryotes. This could 
reflect differences in how the formation of these complexes is controlled between yeast and
147
higher eukaryotes. We propose that in yeast, Slalp undergoes cycles of phosphorylation 
and dephosphorylation allowing cells to spatially and temporally regulate these processes.
In mammalian cells, these processes may be regulated by the availability of N-WASP or its 
ability to interact with Intersectin-I and stimulate its GEF activity.
6.9 Summary and future directions.
In summary, the data presented here indicates that in wild type cells the interaction between 
Slalp and End3p is required to localise Slalp to the cells cortex. Slalp is required for 
efficient endocytosis and may function to bring proteins involved in actin dynamics into 
close proximity to the endocytic machinery and to proteins involved in vesicle trafficking. 
The assembly of these proteins into a complex that promotes endocytosis is regulated by 
cycles of phosphorylation and dephosphorylation mediated by the actin regulating kinases 
and protein phosphatase-1 (Figure 6.1). We propose that Slalp functions to localise actin 
dynamics to the sites of endocytosis but its function is regulated within cells allowing both 
spatial and temporal control of its function (Figure 6.1).
Future directions would include further analysis of how these complexes are controlled.
For example, determining whether Ycl034wp is membrane associated when GTP-Arf 
family proteins are available. This study also provides evidence for the phosphorylation of 
Slalp at sites outside the C-terminal repeat region. Sequence analysis has identified 
potential phosphorylation sites for both protein kinase C and cAMP dependent protein 
kinase within Slalp. These sites may regulate the links between Slalp and proteins 
involved in actin dynamics and vesicle trafficking. Elucidation of how Slalp and its 
interacting partners are regulated will be of value in furthering our understanding of the 
relationship between these essential cellular functions.
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